See veebileht kasutab küpsiseid kasutaja sessiooni andmete hoidmiseks. Veebilehe kasutamisega nõustute ETISe kasutustingimustega. Loe rohkem
Olen nõus

Anneli Uusküla

https://www.etis.ee/CV/Anneli_Uusküla001/est
11.04.1967
737 4195
anneli.uuskula@ut.ee
H-3303-2015

Teenistuskäik

Töökohad ja ametid
01.02.2018–...   
Tartu Ülikool, Meditsiiniteaduste valdkond, peremeditsiini ja rahvatervishoiu instituut, epidemioloogia professor (1,00)
2007–...   
Department of Family Medicine and Public Health, Professor (1,00)
2000–...   
SA Tartu Ülikooli Kliinikum, Tartu Ülikooli Kliinikumi Nahakliinik, arst-õppejõud (0,25)
01.01.2016–31.01.2018   
Tartu Ülikool, Meditsiiniteaduste valdkond, peremeditsiini ja rahvatervishoiu instituut, rahvatervishoiu magistriõppekava programmijuht
01.01.2016–31.01.2018   
Tartu Ülikool, Meditsiiniteaduste valdkond, peremeditsiini ja rahvatervishoiu instituut, epidemioloogia professor (1,00)
01.02.2013–31.12.2015   
Tartu Ülikool, Arstiteaduskond, Arstiteaduskonna dekanaat, rahvatervishoiu magistriõppekava programmijuht
01.02.2013–31.12.2015   
Tartu Ülikool, Arstiteaduskond, Tervishoiu instituut, epidemioloogia professor (1,00)
01.02.2008–31.01.2013   
Tartu Ülikool, Arstiteaduskond, Tervishoiu instituut, epidemioloogia professor (1,00)
01.02.2008–28.02.2009   
Tartu Ülikool, Arstiteaduskond, Tervishoiu instituut, instituudi juhataja
01.03.2007–31.01.2008   
Tartu Ülikool, Arstiteaduskond, Tervishoiu instituut, epidemioloogia erakorraline professor (0,50)
01.03.2007–31.01.2008   
Tartu Ülikool, Arstiteaduskond, Tervishoiu instituut, instituudi juhataja
01.03.2007–31.01.2008   
Tartu Ülikool, Arstiteaduskond, Tervishoiu instituut, epidemioloogia vanemteadur (0,50)
01.02.2007–28.02.2007   
Tartu Ülikool, Arstiteaduskond, Tervishoiu instituut, instituudi juhataja kohusetäitja
2007–2009   
Tartu Ülikool, Arstiteaduskond, Tervishoiu instituut, Juhataja (0,25)
01.01.2005–28.01.2007   
Tartu Ülikool, Arstiteaduskond, Nahahaiguste kliinik, dermatoloogia ja veneroloogia vanemassistent (0,25)
01.05.2004–28.02.2007   
Tartu Ülikool, Arstiteaduskond, Tervishoiu instituut, epidemioloogia vanemteadur (0,75)
 
 
Haridustee
2001–2003   
State University of New York, magistriõpe (epidemioloogia)
1997–2001   
Tartu Ülikool, doktoriõpe
1993–1997   
Tartu Ülikool, residentuur (dermatoveneroloogia)
1991–1993   
Tartu Ülikool, internatuur
1985–1991   
Tartu Ülikool, arstiteaduskond
 
 
Teadusorganisatsiooniline ja -administratiivne tegevus
2019−...   
Eesti teadusagentuur, tervise valdkonna ekspert komimsjon, liige
2013−...   
Ajakirja BMC infectious diseases toimetaja
2012−...   
Eesti ravijuhendite koostamise nõukoda, liige
2011−...   
Ajakiri Eesti arst, teadustoimetaja
2009−...   
Euroopa haiguskontrolli keskus, ekspert
2007−...   
Eesti haigekassa rahvatervise komisjon, liige
2007−...   
Eesti euroopa sotsiaaluuring, juhatuse esimees
2005−...   
Euroopa Ravimiagentuuri (European Medicines Agency, EMEA), valideeritud ekspert
1999−...   
Riigi Ravimiameti ekspert (dermatoloogia)
1997−...   
New York Academy of Sciences liige
2006−2018   
Eesti dermatoveneroloogide selts, president (President) kuni 2012; juhatuse liige alates 2012-2018
2004−2008   
European Surveillance of Sexually Transmitted Infections (ESSTI), töögrupi liige
1999−2010   
Sugulisel teel levivate infektsioonide Eesti Ühing (juhatuse liige)
 
 
Lisainfo
Saadud uuringu toetused (lõpetatud)

National institutes of health (USA)/NIAID R01AI083035
06/2009-08/2014
Juhtpartner - DesJarlais D (Beth Isreal Med Center, NY, USA)
Multiple Prevention Programs Project for IDUs in Eastern Europe (Estonia)

European Commission/ Leonardo da Vinci Programme
01/2013-12/2015
Juhtpartner – McNulty C (HPA, UK)
Chlamydia Testing Training Into Europe (CaTTE)

European Centre for Disease Prevention and Control (ECDC)
01/2012-04/2014
Juhtpartner – Low N (Univ Bern, Switzerland)
Chlamydia Control in Europe

Norwegian Financial Mechanism / EEA grant EE0016
11/2007 – 05/2011
Juhtpartner – Uusküla A/Kiivet R
Capacity building for disease surveillance and health monitoring in Estonia

National institutes of health (USA) / FIC R01 TW06990-01
07/2004-07/2010
Juhtpartner - Uuskula A
Homescreening for sexually transmitted infections in Estonia

Merck (USA) Investigator initiated research program MISP #38078
12/2010-12/2013
Juhtpartner – Uusküla A (Univ Tartu)
The Burden of Genital Warts: a study from three Baltic countries

National institutes of health (USA) / NIDA R01 003574
09/2005 - 08/2010
Juhtpartner - Des Jarlais DC
Risk Factors for AIDS among IV Drug Users

European Centre for Disease prevention and Control OJ/2008/04/11 – PROC/2008/006
06/2008-05/2010
Juhtpartner – Low N
Evaluating the public health benefits of partner notification

Civilian Research & Development Foundation (USA) ESB1-7002-TR-08
10/2008 - 12/2010
Juhtpartner – Uusküla A
HIV Transmission Among Injecting and Non-Injecting Drug Users in Tallinn, Estonia

Civilian Research & Development Foundation (USA) ESXO-002722-TA06
Juhtpartner - Uusküla A
Development of an Intervention/Prevention to Block Transmission from Injection Drug Users to Their Sex Partners.
02/2006-01/2008

Kvalifikatsioon

Teaduskraadid
Anneli Uusküla, magistrikraad (teaduskraad), 2003, (juh) Louise-Anne McNutt, Treatment of the sexually transmitted diseases in Estonia: consistency with the evidence based medicine principles, State University of New York at Albany, School of Public Health.
Anneli Uusküla, doktorikraad, 2001, (juh) Helgi Silm, Epidemiology of sexually transmitted diseases in Estonia in 1990 - 2000 (Seksuaalsel teel levivate haiguste epidemioloogia Eesti aastatel 1990–2000), Tartu Ülikool, Arstiteaduskond.
 
 
Teaduspreemiad ja tunnustused
2001, Anneli Uusküla, NIH Fellowship, Fogarty International Center (2001-2003)
 
 
Teadustöö põhisuunad
ETIS VALDKOND: 3. Terviseuuringud; 3.6. Rahvatervishoid
ETIS VALDKOND: 3. Terviseuuringud; 3.7. Kliiniline meditsiin

Jooksvad projektid

Lõppenud projektid

Juhendamisel väitekirjad

Juhendatud väitekirjad

Publikatsioonid

 
1.1. Teadusartiklid, mis on kajastatud Web of Science andmebaasides Science Citation Index Expanded, Social Sciences Citation Index, Arts & Humanities Citation Index, Emerging Sources Citation Index ja/või andmebaasis Scopus (v.a. kogumikud)
 
Uusküla, A.; Kalda, R.; Solvak, M.; Jürisson, M.; Käärik, M.; Fischer, K.; Keis, A.; Raudvere, U.; Vilo, J.; Peterson, H.; Käärik, E.; Metspalu, M.; Jürgenson, T.; Milani, L.; Kolberg, L.; Tiit, E.-M.; Vassil, K. (2022). The 1st year of the COVID-19 epidemic in Estonia: a population-based nationwide sequential/consecutive cross-sectional study. Public Health, 205, 150−156. DOI: 10.1016/j.puhe.2022.02.004.
 
Uuskula, Anneli; Jürgenson, Tuuli; Pisarev, Heti; Kolde, Raivo; Meister, Tatjana; Tisler, Anna; Suija, Kadri; Kalda, Ruth; Piirsoo, Marko; Fischer, Krista (2022). Long-Term Mortality Following COVID-19 Infection: A National Cohort Study From Estonia. SSRN Electronic Journal. DOI: 10.2139/ssrn.4028547.
 
Anneli Uusküla, Tuuli Jürgenson, Heti Pisarev, Raivo Kolde, Tatjana Meister, Anna Tisler, Kadri Suija, Ruth Kalda, Marko Piirsoo, Krista Fischer (2022). Long-term mortality following COVID-19 infection: a national cohort study from Estonia. The Lancet Regional Health - Europe, x, 100394. DOI: 10.1016/j.lanepe.2022.100394.
 
Uuskula, Anneli; Keis, Aime; Toompere, Karolin; Planken, Anu; Rebrov, Konstantin (2022). Cluster randomised, controlled, triple-blind trial assessing the efficacy of intranasally administered virus-neutralising bovine colostrum supplement in preventing SARS-CoV-2 infection in household contacts of SARS-CoV-2-positive individuals: a study protocol. Trials, 23 (1), ARTN 92. DOI: 10.1186/s13063-022-06039-9.
 
Uusküla A, Talu A, Rannap J, Barnes DM, Des Jarlais D. (2021). Rapid point-of-care (POC) testing for Hepatitis C antibodies in a very high prevalence setting: persons injecting drugs in Tallinn, Estonia. Harm Reduction Journal, 18 (1), 39. DOI: 10.1186/s12954-021-00485-5.
 
Wiessing L, Kalamara E, Stone J, ... Dolan K, Uusküla A, Vickerman P. (2021). Univariable associations between a history of incarceration and HIV and HCV prevalence among people who inject drugs across 17 countries in Europe 2006 to 2020 - is the precautionary principle applicable? Eurosurveillance, 26 (49). DOI: 10.2807/1560-7917.ES.2021.26.49.2002093.
 
Jürisson, Mikk; Pisarev, Heti; Uusküla, Anneli; Lang, Katrin; Oona, Marje; Elm, Lisanna; Kalda, Ruth (2021). Physical-mental health comorbidity: A population-based cross-sectional study. PLoS ONE, 16 (12), e0260464. DOI: 10.1371/journal.pone.0260464.
 
Jürisson, Mikk; Pisarev, Heti; Uusküla, Anneli; Lang, Katrin; Oona, M; Kalda, Ruth (2021). Prevalence of chronic conditions and multimorbidity in Estonia: a population-based cross-sectional study. BMJ Open, 11 (10), 1−7. DOI: 10.1136/bmjopen-2021-049045.
 
Des Jarlais, Don C.; Arasteh, Kamyar; Barnes, David M.; Feelemyer, Jonathan; Berg, Hayley; Raag, Mait; Talu, Ave; Org, Greete; Tross, Susan; Uuskula, Anneli (2021). A Multistage Process Model of How a Person Who Currently Injects Drugs Comes to Assist Persons Who Do not Inject with Their First Injections. Frontiers in Sociology, 6, ARTN 619560. DOI: 10.3389/fsoc.2021.619560.
 
Tisler, Anna; Ojavee, Sven Erik; Veerus, Piret; Soodla, Pilleriin; Uuskuela, Anneli (2021). Cervical cancer screening patterns among HIV-positive women in Estonia: a population-based retrospective cohort study. BMC Cancer, 21 (1), ARTN 350. DOI: 10.1186/s12885-021-08076-0.
 
Uusküla, Anneli; Raag, Mait; Kurvits, Katrin; Laius, Ott; Uusküla, Maia; Oselin, Kersti (2020). Trends in opioid prescribing in Estonia (2011-2017). Pharmacology Research & Perspectives, 8 (2), e00577−e00577. DOI: 10.1002/prp2.577.
 
Uuskula, Anneli; Talu, Ave; Vorobjov, Sigrid; Salekesin, Maris; Rannap, Jurgen; Lemsalu, Liis; Jarlais, Don Des (2020). The fentanyl epidemic in Estonia: factors in its evolution and opportunities for a comprehensive public health response, a scoping review. International Journal of Drug Policy, 81, ARTN 102757. DOI: 10.1016/j.drugpo.2020.102757.
 
Uusküla A, Vickerman P, Raag M, et al. (2020). Presenting a conceptual framework for an HIV prevention and care continuum and assessing the feasibility of empirical measurement in Estonia: A case study. PLoS ONE, 15 (10), e0240224. DOI: 10.1371/journal.pone.0240224.
 
Raag, Mait; Vorobjov, Sigrid; Uusküla, Anneli (2019). Prevalence of injecting drug use in Estonia 2010-2015: a capture-recapture study. Harm Reduction Journal, 16 (1), 19−19. DOI: 10.1186/s12954-019-0289-3.
 
Des Jarlais, Don; Uuskula, Anneli; Talu, Ave; Barnes, David M; Raag, Mait; Arasteh, Kamyar; Org, Greete; Demarest, Donna; Feelemyer, Jonathan; Berg, Hayley; Tross, Susan (2019). Implementing an Updated "Break the Cycle" Intervention to Reduce Initiating Persons into Injecting Drug Use in an Eastern European and a US "opioid epidemic" Setting. AIDS and Behavior, 23 (9), 2304−2314. DOI: 10.1007/s10461-019-02467-y.
 
Tavitian-Exley, Isabel; Maheu-Giroux, Mathieu; Platt, Lucy; Heimer, Robert; Uusküla, Anneli; Levina, Olga; Vickerman, Peter; Boily, Marie-Claude (2018). Differences in risk behaviours and HIV status between primary amphetamines and opioid injectors in Estonia and Russia. The International journal on drug policy, 53, 96−105.10.1016/j.drugpo.2017.11.010.
 
Werb, Dan; Bluthenthal, R. N.; Kolla, G.; Strike, C.; Kral, A. H.; Uuskula, A.; Des Jarlais, D. (2018). Preventing Injection Drug use Initiation: State of the Evidence and Opportunities for the Future. Journal of Urban Health, 95 (1), 91−98.10.1007/s11524-017-0192-8.
 
Chan, Pui Y; Joseph, Michael A; Des Jarlais, Don C; Uusküla, Anneli (2018). Perceived effectiveness of antiretroviral therapy, self-rated health and treatment adherence among HIV-positive people who inject drugs in Estonia. International Journal of STD & AIDS, 29 (1), 13−22. DOI: 10.1177/0956462417714635.
 
Uusküla, Anneli; Laisaar, Kaja-Triin; Raag, Mait; Lemsalu, Liis; Lõhmus, Liilia; Rüütel, Kristi; Amico, K. Rivet; HIV-BRIDGE Study Group (2018). Effects of Counselling on Adherence to Antiretroviral Treatment Among People with HIV in Estonia: A Randomized Controlled Trial. AIDS and Behavior, 22 (1), 224−233. DOI: 10.1007/s10461-017-1859-6.
 
Jõgeda, E-L; Avi, R; Pauskar, M; Kallas, E; Karki, T; Des Jarlais, D; Uusküla, A; Toompere, K; Lutsar, I; Huik, K (2018). Association of IFNλ4 rs12979860 polymorphism with the acquisition of HCV and HIV infections among people who inject drugs. Journal of Medical Virology, 90 (11), 1779−1783. DOI: 10.1002/jmv.25258.
 
Tavitian-Exley, Isabel; Boily, Marie-Claude; Heimer, Robert; Uuskula, Anneli; Levina, Olga; Maheu-Giroux, Mathieu (2018). Polydrug Use and Heterogeneity in HIV Risk Among People Who Inject Drugs in Estonia and Russia: A Latent Class Analysis. AIDS and Behavior, 22 (4), 1329−1340.10.1007/s10461-017-1836-0.
 
Tisler-Sala, Anna; Ojavee, Sven-Erik; Uuskula, Anneli (2018). Treatment of chlamydia and gonorrhoea, compliance with treatment guidelines and factors associated with non-compliant prescribing: findings form a cross-sectional study. Sexually Transmitted Infections, 94 (4), 297−302. DOI: 10.1136/sextrans-2017-053247.
 
Kivimets, Kristel; Uuskula, Anneli; Lazarus, Jeffrey V.; Ott, Kristi (2018). Hepatitis C seropositivity among newly incarcerated prisoners in Estonia: data analysis of electronic health records from 2014 to 2015. BMC Infectious Diseases, 18, ARTN 339. DOI: 10.1186/s12879-018-3242-2.
 
Uusküla, Anneli; Pisarev, Heti; Kurvits, Katrin; Laius, Ott; Laanpere, Made; Uusküla, Maia (2018). Compliance with Pregnancy Prevention Recommendations for Isotretinoin in Estonia in 2012-2016. Drugs - Real World Outcomes, 5 (2), 129−136. DOI: 10.1007/s40801-018-0135-z.
 
Des Jarlais, Don C.; Arasteh, K.; Feelemyer, J.; McKnight, C.; Barnes, David M.; Perlman, David C.; Uuskula, A.; Cooper, H. L. F.; Tross, Susan (2018). Hepatitis C virus prevalence and estimated incidence among new injectors during the opioid epidemic in New York City, 2000-2017: Protective effects of non-injecting drug use. Drug and Alcohol Dependence, 192, 74−79. DOI: 10.1016/j.drugalcdep.2018.07.034.
 
Uusküla, Anneli; Raag, Mait; Vorobjov, Sigrid; Des Jarlais, Don (2018). Another frontier for harm reduction: contraceptive needs of females who inject drugs in Estonia, a cross-sectional study. Harm Reduction Journal, 15, ARTN 10. DOI: 10.1186/s12954-018-0215-0.
 
Uuskula, Anneli; Barnes, David M.; Raag, Mait; Talu, Ave; Tross, Susan; Des Jarlais, Don C. (2018). Frequency and factors associated with providing injection initiation assistance in Tallinn, Estonia. Drug and Alcohol Dependence, 188, 64−70. DOI: 10.1016/j.drugalcdep.2018.03.048.
 
Johannson A, Vorobjov S, Heimer R, Dovidio JF, Uusküla A. (2017). The Role of Internalized Stigma in the Disclosure of Injecting Drug Use Among People Who Inject Drugs and Self-Report as HIV-Positive in Kohtla-Järve, Estonia. AIDS and Behavior, 21 (4), 1034−1043. DOI: 10.1007/s10461-016-1647-8.
 
Anneli Uusküla, Mait Raag, Kristina Marsh, Ave Talu, Sigrid Vorobjov, Don Des Jarlais (2017). HIV prevalence and gender differences among new injection-drug-users in Tallinn, Estonia: A persisting problem in a stable high prevalence epidemic. PLoS ONE, 12 (2), e0170956. DOI: 10.1371/journal.pone.0170956.
 
Jogeda, Ene-Ly; Huik, Kristi; Pauskar, Merit; Kallas, Eveli; Karki, Tonis; Jarlais, Don Des; Uuskula, Anneli; Lutsar, Irja; Avi, Radko (2017). Prevalence and Genotypes of GBV-C and Its Associations With HIV Infection Among Persons Who Inject Drugs in Eastern Europe. Journal of Medical Virology, 89 (4), 632−638. DOI: 10.1002/jmv.24683.
 
Wu, Jiacheng; Crawford, Forrest W; Raag, Mait; Heimer, Robert; Uusküla, Anneli (2017). Using data from respondent-driven sampling studies to estimate the number of people who inject drugs: Application to the Kohtla-Järve region of Estonia. PLoS ONE, 12 (11), e0185711−e0185711.10.1371/journal.pone.0185711.
 
Mikk Jürisson, Mait Raag, Riina Kallikorm, Margus Lember, Anneli Uusküla (2017). The impact of hip fracture on mortality in Estonia: a retrospective population-based cohort study. BMC Musculoskeletal Disorders, 18 (243), 1−10. DOI: 10.1186/s12891-017-1606-1.
 
Võrno, Triin; Lutsar, Katrin; Uusküla, Anneli; Padrik, Lee; Raud, Terje; Reile, Rainer; Nahkur, Oliver; Kiivet, Raul-Allan (2017). Cost-effectiveness of HPV vaccination in the context of high cervical cancer incidence and low screening coverage. Vaccine, 35 (46), 6329−6335. DOI: 10.1016/j.vaccine.2017.08.083.
 
Heimer, Robert; Usacheva, Nina; Barbour, Russell; Niccolai, Linda M; Uusküla, Anneli; Levina, Olga S (2017). Engagement in HIV care and its correlates among people who inject drugs in St Petersburg, Russian Federation and Kohtla-Järve, Estonia. Addiction, 112 (8), 1421−1431. DOI: 10.1111/add.13798.
 
McNulty C, Ricketts EJ, Fredlund H, Uusküla A, Town K, Rugman C, Tisler-Sala A, Mani A, Dunais B, Folkard K, Allison R, Touboul P. (2017). Qualitative interviews with healthcare staff in four European countries to inform adaptation of an intervention to increase chlamydia testing. BMJ Open, 7 (9), e017528. DOI: 10.1136/bmjopen-2017-017528.
 
Wiessing, Lucas; Ferri, Marica; Běláčková, Vendula; Carrieri, Patrizia; Friedman, Samuel R; Folch, Cinta; Dolan, Kate; Galvin, Brian; Vickerman, Peter; Lazarus, Jeffrey V; Mravčík, Viktor; Kretzschmar, Mirjam; Sypsa, Vana; Sarasa-Renedo, Ana; Uusküla, Anneli; Paraskevis, Dimitrios; Mendão, Luis; Rossi, Diana; van Gelder, Nadine; Mitcheson, Luke ... Griffiths, Paul (2017). Monitoring quality and coverage of harm reduction services for people who use drugs: a consensus study. Harm Reduction Journal, 14 (1), 19−19. DOI: 10.1186/s12954-017-0141-6.
 
Lemsalu, L.; Rüütel, K.; Laisaar, KT.; Lõhmus, L.; Raidvee, A.; Uusküla, A.; HIV-BRIDGE Study Group (2017). Suicidal Behavior Among People Living with HIV (PLHIV) in Medical Care in Estonia and Factors Associated with Receiving Psychological Treatment. AIDS and Behavior, 21 (6), 1709−1716. DOI: 10.1007/s10461-016-1561-0.
 
Huik, Kristi; Avi, Radko; Pauskar, Merit; Kallas, Eveli; Jõgeda, Ene-Ly; Karki, Tõnis; Rüütel, Kristi; Talu, Ave; Abel-Ollo, Katri; Uusküla, Anneli; Carrillo, Andrew; Ahuja, Sunil K; He, Weijing; Lutsar, Irja (2016). A CCL5 Haplotype Is Associated with Low Seropositivity Rate of HCV Infection in People Who Inject Drugs. PLoS ONE, 11 (6), e0156850−e0156850. DOI: 10.1371/journal.pone.0156850.
 
van den Broek, Ingrid V.; Sfetcu, Otilia; van der Sande, Marianne A.; Andersen, Berit; Herrmann, Björn; Ward, Helen; Götz, Hannelore M.; Uusküla, Anneli; Woodhall, Sarah C.; Redmond, Shelagh M.; Amato-Gauci, Andrew J.; Low, Nicola; van Bergen, Jan E. (2016). Changes in chlamydia control activities in Europe between 2007 and 2012: a cross-national survey. European Journal of Public Health, 26 (3), 382−388. DOI: 10.1093/eurpub/ckv196.
 
Calabrese, Sarah K.; Burke, Sara E.; Dovidio, John F.; Levina, Olga S.; Uusküla, Anneli; Niccolai, Linda M.; Heimer, Robert (2016). Internalized HIV and Drug Stigmas: Interacting Forces Threatening Health Status and Health Service Utilization Among People with HIV Who Inject Drugs in St. Petersburg, Russia. AIDS and Behavior, 20 (1), 85−97. DOI: 10.1007/s10461-015-1100-4.
 
Low, N.; Redmond, S.; Uusküla, A.; van Bergen, J.; Ward, H.; Andersen, B.; Götz, H. (2016). Screening for genital chlamydia infection. Cochrane Database of Systematic Reviews, 2016 (9), Article number CD010866. DOI: 10.1002/14651858.CD010866.pub2.
 
Jürisson, Mikk; Pisarev, Heti; Kanis, John; Borgström, Fredrik; Svedbom, Axel; Kallikorm, Riina; Lember, Margus; Uusküla, Anneli (2016). Quality of life, resource use, and costs related to hip fracture in Estonia. Osteoporosis International, 27 (8), 2555−2566. DOI: 10.1007/s00198-016-3544-4.
 
Kallas, Eveli; Huik, Kristi; Türk, Silver; Pauskar, Merit; Jõgeda, Ene-Ly; Šunina, Marina; Karki, Tõnis; Des Jarlais, Don; Uusküla, Anneli; Avi, Radko; Lutsar, Irja (2016). Differences in T cell distribution and CCR5 expression in HIV-positive and HIV-exposed seronegative persons who inject drugs. Medical Microbiology and Immunology, 205 (3), 231−239. DOI: 10.1007/s00430-015-0444-8.
 
Jõgeda, Ene-Ly; Avi, Radko; Pauskar, Merit; Kallas, Eveli; Karki, Tõnis; Des Jarlais, Don; Uusküla, Anneli; Lutsar, Irja; Huik, Kristi (2016). Human T-lymphotropic virus types 1 and 2 are rare among intravenous drug users in Eastern Europe. Infection Genetics and Evolution, 43, 83−85. DOI: 10.1016/j.meegid.2016.05.022.
 
Kallas, Eveli; Huik, Kristi; Türk, Silver; Pauskar, Merit; Jõgeda, Ene-Ly; Šunina, Marina; Karki, Tõnis; Des Jarlais, Don; Uusküla, Anneli; Avi, Radko; Lutsar, Irja (2016). T Cell Distribution in Relation to HIV/HBV/HCV Coinfections and Intravenous Drug Use. Viral Immunology, 0−0. DOI: 10.1089/vim.2016.0057.
 
Laisaar, K.T.; Raag, M.; Lutsar, I.; Uusküla, A. (2016). People living with HIV in Estonia: engagement in HIV care in 2013. Eurosurveillance, 21 (43), x−x. DOI: 10.2807/1560-7917.ES.2016.21.43.30380.
 
Uusküla, Anneli; Reile, Rainer; Rezeberga, Dace; Karnite, Anda; Logminiene, Zenetha; Padaiga, Zilvinas; Nygård, Mari. (2015). The prevalence of genital warts in the Baltic countries: findings from national cross-sectional surveys in Estonia, Latvia and Lithuania. Sexually Transmitted Infections, 91 (1), 55−60. DOI: 10.1136/sextrans-2014-051540.
 
Shelagh M. Redmond, Karin Alexander-Kisslig, Sarah C. Woodhall, Ingrid V. F. van den Broek, Jan van Bergen, Helen Ward, Anneli Uusküla, Björn Herrmann, Berit Andersen, Hannelore M. Götz, Otilia Sfetcu, Nicola Low (2015). Genital Chlamydia prevalence in europe and non-European high income countries: systematic review and meta-analysis. PLoS ONE, 10 (1), e0115753. DOI: 10.1371/journal.pone.0115753.
 
Uusküla, A.; Erm, T. (2015). Disseminated Giant Hyperkeratotic Porokeratosis and Treatment with Acitretin: A Case Report. Acta Dermato Venereologica, 95 (2), 241−242. DOI: 10.2340/00015555-1908.
 
Feelemyer, J.; Des Jarlais, D.; Arasteh, K.; Uusküla, A. (2015). Adherence to Antiretroviral Medications Among Persons Who Inject Drugs in Transitional, Low and Middle Income Countries: An International Systematic Review. AIDS and Behavior, 19 (4), 575−583.10.1007/s10461-014-0928-3.
 
Perlman DC, Jordan AE, Uuskula A, Huong DT, Masson CL, Schackman BR, Des Jarlais DC. (2015). An international perspective on using opioid substitution treatment to improve hepatitis C prevention and care for people who inject drugs: Structural barriers and public health potential. International Journal of Drug Policy, S0955-3959(15)00126-7.
 
Uusküla, A.; Des Jarlais, D.C.; Raag, M.; Pinkerton, S.D.; Feelemyer, J. (2015). Combined prevention for persons who inject drugs in the HIV epidemic in a transitional country: the case of Tallinn, Estonia. AIDS Care, 27 (1), 105−11. DOI: 10.1080/09540121.2014.940271.
 
Jürisson, Mikk; Vorobjov, Sigrid; Kallikorm, Riina; Lember, Margus; Uusküla, Anneli. (2015). The incidence of hip fractures in Estonia, 2005–2012. Osteoporosis International, 26 (1), 77−84. DOI: 10.1007/s00198-014-2820-4.
 
Morozova, Olga; Levina, Olga; Uusküla, Anneli; Heimer, Robert (2015). Comparison of subset selection methods in linear regression in the context of health-related quality of life and substance abuse in Russia. BMC Medical Research Methodology, 15 (71), 71−71.10.1186/s12874-015-0066-2.
 
Burke, Sara E.; Calabrese, Sarah K.; Dovidio, John F.; Levina, Olga S.; Uusküla, Anneli; Niccolai, Linda M.; Abel-Ollo, Katri; Heimer, Robert (2015). A tale of two cities: Stigma and health outcomes among people with HIV who inject drugs in St. Petersburg, Russia and Kohtla-Järve, Estonia. Social Science & Medicine, 130, 154−161. DOI: 10.1016/j.socscimed.2015.02.018.
 
Laisaar, Kaja-Triin; Raag, Mait; Rosenthal, Marika; Uusküla, Anneli (2015). Behavioral Interventions to Reduce Sexual Risk Behavior in Adults with HIV/AIDS Receiving HIV Care: A Systematic Review. AIDS Patient Care and STDs, 29 (5), 288−289. DOI: 10.1089/apc.2014.0240.
 
Uuskuela, Anneli; Raag, Mait; Vorobjov, Sigrid; Rueuetel, Kristi; Lyubimova, Alexandra; Levina, Olga S.; Heimer, Robert (2015). Non-fatal overdoses and related risk factors among people who inject drugs in St. Petersburg, Russia and Kohtla-Jarve, Estonia. BMC Public Health, 15, ARTN 1255. DOI: 10.1186/s12889-015-2604-6.
 
Uusküla, A.; Toompere, K.; Laisaar, KT.; Rosenthal, M.; Pürjer, ML.; Knellwolf, A.; Läärä, E.; Des Jarlais, DC. (2015). HIV research productivity and structural factors associated with HIV research output in European Union countries: a bibliometric analysis. BMJ Open, 5 (2), e006591−8. DOI: 10.1136/bmjopen-2014-006591.
 
Kivimets K, Uuskula A. (2014). HIV testing and counselling in Estonian prisons, 2012 to 2013: aims, processes and impacts. Eurosurveillance, 19 (47), 31−37.
 
Uusküla A, Ricketts EJ, Rugman C, Kalda RR, Fredlund H, Hedlund J, Dunais B, Touboul PP, McNulty C (2014). Provision of chlamydia testing, and training of primary health care staff about chlamydia testing, across four European countries. BMC Public Health, 14, 1147.10.1186/1471-2458-14-1147.
 
DeHovitz, J.; Uuskula, A.; El-Bassel, N. (2014). The HIV epidemic in Eastern Europe and Central Asia. Current HIV/AIDS Reports, 11 (2), 168−176.10.1007/s11904-014-0202-3.
 
Huik, K.; Avi, R.; Uibopuu, H.; Pauskar, M.; Margus, T.; Karki, T.; Krispin, T.; Kool, P.; Rüütel, K.; Talu, A.; Abel-Ollo, K.; Uusküla, A.; Carrillo, AQ.; He, W.; Ahuja, SK.; Lutsar, I. (2014). Association between HIV-1 tropism and CCR5 human haplotype E in a Caucasian population. JAIDS: Journal of Acquired Immune Deficiency Syndromes, 66 (3), 239−244. DOI: 10.1097/QAI.0000000000000127.
 
Rüütel, Kristi; Karnite, Anda; Talu, Ave; Abel-Ollo, Katri; Kirvelaite, Gunta; Kliiman, Kai; Loit, Helle-Mai; Uusküla, Anneli. (2014). Prevalence of IGRA-positivity and risk factors for tuberculosis among injecting drug users in Estonia and Latvia. International Journal of Drug Policy, 25 (1), 175−178. DOI: 10.1016/j.drugpo.2013.10.002.
 
Rahu, K.; Bromet, E. J.; Hakulinen, T.; Auvinen, A.; Uusküla, A.; Rahu, M. (2014). Non-cancer morbidity among Estonian Chernobyl cleanup workers: a register-based cohort study. BMJ Open, 4, e004516. DOI: 10.1136/bmjopen-2013-004516.
 
Uusküla, A.; Raag, M.; Folch, C.; Prasad, L.; Karnite, A.; van Veen, M.G.; Eritsyan, K.; Rosinska, M.; Des Jarlais, D.C.; Wiessing, L. (2014). Self-reported testing, HIV status and associated risk behaviours among people who inject drugs in Europe: important differences between East and West. AIDS, 28 (11), 1657−64.10.1097/QAD.0000000000000299.
 
Liivlaid, H; Uusküla, A (2013). Changes in high-risk sexual behaviour among Estonian adults between 1996 and 2006. Sexually Transmitted Infections, 89 (2), 91−97.10.1136/sextrans-2012-050506.
 
Karnite, A.; Brigis, G.; Uusküla, A. (2013). Years of potential life lost due to HIV infection and associated factors based on national HIV surveillance data in Latvia, 1991-2010. Scandinavian Journal of Infectious Diseases, 45 (2), 140−146.10.3109/00365548.2012.717710.
 
Vickerman, P; Martin, NK; Roy, A; Beattie, T; EMCDDA Collaborative Group, Jarlais, DD; Strathdee, S; Wiessing, L; Hickman, M (2013). Is the HCV-HIV co-infection prevalence amongst injecting drug users a marker for the level of sexual and injection related HIV transmission? Drug and Alcohol Dependence, 132, 172−182.10.1016/j.drugalcdep.2013.01.020.
 
Laisaar, KT; Uusküla, A; Sharma, A; DeHovitz, JA; Amico, KR (2013). Developing an adherence support intervention for patients on antiretroviral therapy in the context of the recent IDU-driven HIV/AIDS epidemic in Estonia. AIDS Care, 25 (7), 863−873. DOI: 10.1080/09540121.2013.764393.
 
Huik, K; Avi, R; Pauskar, M; Kallas, E; Jõgeda, EL; Karki, T; Marsh, K; Des Jarlais, D; Uusküla, A; Lutsar, I (2013). Association between TLR3 rs3775291 and resistance to HIV among highly exposed Caucasian intravenous drug users. Infection Genetics and Evolution, 20, 78−82. DOI: 10.1016/j.meegid.2013.08.008.
 
Huik, K; Avi, R; Carrillo, A; Harper, N; Pauskar, M; Sadam, M; Karki, T; Krispin, T; He, W; Lutsar, I (2013). CCR5 Haplotypes Influence HCV Serostatus in Caucasian Intravenous Drug Users. PLoS ONE, 8 (7), e70561. DOI: 10.1371/journal.pone.0070561.
 
Uusküla, Anneli; Rajaleid, Kristiina; Talu, Ave; Abel-Ollo, Katri; Des Jarlais, Don (2013). A decline in the prevalence of injecting drug users in Estonia, 2005–2009. International Journal of Drug Policy, 24 (4), 312−318. DOI: 10.1016/j.drugpo.2012.11.002.
 
Vorobjov, S; Des Jarlais, DC; Abel-Ollo, K; Talu, A; Rüütel, K; Uusküla, A (2013). Socio-demographic factors, health risks and harms associated with early initiation of injection among people who inject drugs in Tallinn, Estonia: Evidence from cross-sectional surveys. International Journal of Drug Policy, 24 (2), 150−155. DOI: 10.1016/j.drugpo.2012.08.003.
 
Puur, A., Altmets, K., Saava, A., Uusküla, A., Sakkeus, L. (2013). Non-fatal injuries resulting in activity limitations in Estonia: risk factors and association with the incidence of chronic conditions and quality of life. A retrospective study among the population aged 20-79. BMJ Open, 3, 1−7. DOI: 10.1136/bmjopen-2013-002695.
 
Anneli Uusküla, A.; Müürsepp, A.; Kawai, K.; Raag, M.; Jürisson, M.; Pillsbury, M. (2013). The epidemiological and economic impact of a quadrivalent human papillomavirus (hpv) vaccine in Estonia. BMC Infectious Diseases, 13, No 304. DOI: 10.1186/1471-2334-13-304.
 
Uusküla, A.; Raag, M.; Uppin, A.; Raud, T.; Klaar, U.; Jürisson, M.; Müürsepp, A. (2013). Incidence of Cervical Intraepithelial Neoplasia in Estonia. Journal of Lower Genital Tract Disease, 17 (2), 129−136. DOI: 10.1097/LGT.0b013e3182652213.
 
Uusküla, A.; Laisaar, K.-T.; Raag, M.; Smidt, J.; Semjonova, S.; Kogan, J.; Amico K, R.; Sharma, A.; Dehovitz , J. (2012). Antiretroviral therapy (ART) adherence and correlates to nonadherence among people on ART in Estonia. AIDS Care, 24 (12), 1470−1479. DOI: 10.1080/09540121.2012.672724.
 
Vorobjov S, Uusküla A, Des Jarlais DC, Abel-Ollo K, Talu A, Rüütel K. (2012). Multiple routes of drug administration and HIV risk among injecting drug users. Journal of Substance Abuse Treatment, 42 (4), 413−420.
 
Uusküla, A.; Abel-Ollo, K.; Markina, A.; McNutt, LA.; Heimer, R. (2011). Condom use and partnership intimacy among drug injectors and their sexual partners in Estonia. Sexually Transmitted Infections, 88 (1), 58−62. DOI: 10.1136/sextrans-2011-050195.
 
Uusküla, A.; Kals, M; McNutt, LA. (2011). Assessing non-response to a mailed health survey including self-collection of biological material. European Journal of Public Health, 21 (4), 538−542.10.1093/eurpub/ckq053.
 
Laisaar, K.-T.; Avi, R.; Dehovitz, J.; Uusküla, A. (2011). Estonia at the Threshold of the Fourth Decade of the AIDS Era in Europe. Aids Research and Human Retroviruses, 27 (8), 841−851. DOI: 10.1089/aid.2010.0223.
 
Uusküla A, Des Jarlais DC, Kals M, Rüütel K, Abel-Ollo K, Talu A, Sobolev I. (2011). Expanded syringe exchange programs and reduced HIV infection among new injection drug users in Tallinn, Estonia. BMC Public Health, 30 (11), 517. DOI: 10.1186/1471-2458-11-517.
 
Altmets, K.; Puur, A. ; Uusküla, A.; Saava, A.; Sakkeus, L.; Katus, K. (2011). Self-reported activity limitations among the population aged 20-79 in Estonia: a cross-sectional study. European Journal of Public Health, 21 (1), 49−55. DOI: 10.1093/eurpub/ckp239.
 
Uusküla, A.; Kals, M.; Kosenkranius, L.; McNutt, LA.; DeHovitz, JJ. (2010). Population-based type-specific prevalence of high-risk human papillomavirus infection in Estonia. BMC Infectious Diseases, 10, Article Number: 63.10.1186/1471-2334-10-63.
 
Uusküla, A.; McMahon, JM.; Raag, M.; Silm, S.; Rüütel, K.; Talu, A.; Abel-Ollo, K.; Ahas, R.; Des Jarlais, DC. (2010). Emergent properties of HIV risk among injection drug users in Tallinn, Estonia: synthesis of individual and neighbourhood-level factors. Sexually Transmitted Infections, 86, 3, 79−84. DOI: 10.1136/sti.2009.040212.
 
Uusküla, A.; Johnston, L.G.; Raag, M.; Trummal, A.; Talu, A.; Des Jarlais, D.C. (2010). Evaluating recruitment among female sex workers and injecting drug users at risk for HIV using respondent driven sampling in Estonia. Journal of Urban Health, 87 (2), 304−317. DOI: 10.1007/s11524-009-9427-7.
 
Talu, A.; Rajaleid, K.; Abel-Ollo, K.; Rüütel, K.; Rahu, M.; Rhodes, T.; Platt, L.; Bobrova, N.; Uusküla, A. (2010). HIV infection and risk behaviour of primary fentanyl and amphetamine injectors in Tallinn, Estonia: Implications for intervention. International Journal of Drug Policy, 21 (1), 56−63. DOI: 10.1016/j.drugpo.2009.02.007.
 
Huik, K.; Sadam, M.; Karki, T.; Avi, R.; Krispin, T.; Paap, P.; Rüütel, K.; Uusküla, A.; Talu, A.; Abel-Ollo, K.; Lutsar, I. (2010). CCL3L1 copy number is a strong genetic determinant of HIV seropositivity in Caucasian intravenous drug users. The Journal of Infectious Diseases, 730−739. DOI: 10.1086/650491.
 
Uusküla A, Puur A, Toompere K, DeHovitz J. (2010). Trends in the epidemiology of bacterial sexually transmitted infections in Eastern Europe, 1995-2005: review. Sexually Transmitted Infections, 86, 6−14. DOI: 10.1136/sti.2009.037044.
 
McNutt, L.A.; Gordon, EJ; Uuskula, A. (2009). Informed recruitment in partner studies of HIV transmission: an ethical issue in couples research. BMC Medical Ethics, 10, 14.
 
Vorobjov, S.; Uusküla, A.; Abel-Ollo, K.; Talu, A.; Des Jarlais, D. (2009). Should pharmacists have a role in harm reduction services for IDUs? A qualitative study in Tallinn, Estonia. Journal of Urban Health, 86 (6), 918−928.
 
Abel-Ollo, K.; Rahu, M.; Rajaleid, K.; Talu, A.; Rüütel, K.; Platt, L.; Bobrova, N.; Rhodes, T.; Uusküla, A. (2009). Knowledge of HIV serostatus and risk behaviour among injecting drug users in Estonia. AIDS Care, 21 (7), 851−857.
 
Vorobjov, S.; Uuskula, A.; Abel-Ollo, K.; Talu, A.; Ruutel, K.; Des Jarlais, D.C. (2009). Comparison of injecting drug users who obtain syringes from pharmacies and syringe exchange programs in Tallinn, Estonia. Harm Reduction Journal, 6 (1), 3.
 
Uusküla, A.; Fischer, K.; Raudne, R.; Kilgi, H.; Krylov, R.; Salminen, M.; Brummer-Korvenkontio, H.; St Lawrence, J.; Aral, S. (2008). A study on HIV and hepatitis C virus among commercial sex workers in Tallinn. Sexually Transmitted Infections, 84 (3), 189−191. DOI: 10.1136/sti.2007.027664.
 
Uusküla, A.; Kals, M.; Denks, K.; Nurm, U.; Kasesalu, L.; Dehovitz, J.; McNutt, L.A. (2008). The prevalence of chlamydial infection in Estonia: a poplation-based survey. International Journal of STD & Aids, 19 (7), 455−458. DOI: 10.1258/ijsa.2008.007325.
 
Uusküla, A.; Kals, M.; Rajaleid, K.; Abel, K.; Talu, A.; Rüütel, K.; Platt, L.; Rhodes, T.; Dehovitz, J.; Des Jarlais, D. (2008). High-prevalence and high-estimated incidence of HIV infection among new injecting drug users in Estonia: need for large scale prevention programs. Journal of Public Health, 30 (2), 119−125. DOI: 10.1093/pubmed/fdn014.
 
Uusküla, A.; McNutt, L.A.; Dehovitz, J.; Fischer, K.; Heimer, R. (2007). High prevalence of blood-borne virus infections and high-risk behaviour among injecting drug users in Tallinn, Estonia. International Journal of STD & AIDS, 18 (1), 41−46.
 
Wilson, T.E.; Sharma, A.; Zilmer, K.; Kalikova, N.; Uusküla, A. (2007). The HIV prevention needs of injection drug users in Estonia. International Journal of STD & Aids, 18 (6), 389−391.
 
Uusküla, A.; Rajaleid, K.; Talu, A.; Abel, K.; Rüütel, K.; Hay, G. (2007). Estimating injection drug use prevalence using state wide administrative data sources: Estonia, 2004. Addiction Research & Theory, 15 (4), 411−424.
 
Uuskula, A.; Heimer, R.; DeHovitz, J.; Fischer, K.; McNutt, LA. (2006). Surveillance of HIV, hepatitis B virus, and hepatitis c virus in an Estonian injection drug-using population: Sensitivity and specificity of testing syringes for public health surveillance. The Journal of Infectious Diseases, 193 (3), 455−457.
 
Aral, S.O.; St Lawrence, J.S.; Uusküla, A. (2006). Sex Work in Tallinn, Estonia: The Socio-spatial Penetration of Sex Work into Society. Sexually Transmitted Infections, 82 (5), 348−353.
 
Platt, L.; Bobrova, N.; Rhodes, T.; Uusküla, A.; Parry, JV.; Rüütel, K.; Talu, A.; Abel, K.; Rajaleid, K.; Judd, A. (2006). High HIV prevalence among injecting drug users in Estonia: implications for understanding the risk environment. AIDS, 20 (16), 2120−2123.
 
Uuskula, A.; Kangur, K.; McNutt, L.A. (2006). Barriers to effective STI screening in a post-Soviet society: results from a qualitative study. Sexually Transmitted Infections, 82 (4), 323−326.
 
Rüütel, K.; Uusküla, A. (2006). HIV epidemic in Estonia in the third decade of AIDS era. Scandinavian Journal of Infectious Diseases, 38 (3), 181−186.
 
Naaber, P.; Uuskula, A.; Naaber, J.; Poder, A.; Hjelm, E.; Hallen, A.; Unemo, M.; Domeika, M. (2005). Laboratory diagnosis of sexually transmitted infections in Estonia in 2001-2002: Shortcomings with impact on diagnostic quality and surveillance. Sexually Transmitted Diseases, 32 (12), 759−764.
 
Uuskula, A.; Raukas, E. (2004). Atypical genital herpes: Report of five cases. Scandinavian Journal of Infectious Diseases, 36 (1), 37−39.
 
Uuskula, A.; Nygard-Kibur, M.; Cowan, FM.; Mayaud, P.; French, RS.; Robinson, JNR.; Brown, DWG. (2004). The burden of infection with herpes simplex virus type 1 and type 2: Seroprevalence study in Estonia. Scandinavian Journal of Infectious Diseases, 36 (10), 727−732.
 
Uuskula, A.; McNutt, LA.; Dehovitz, J. (2004). Treatment of sexually transmitted diseases in Estonia - Consistency with the evidence-based medicine principles. Sexually Transmitted Diseases, 31 (10), 631−635.
 
Uuskula, A.; Nygard, JF.; Kibur-Nygard, M. (2004). Syphilis as a social disease: experience from the post-communist transition period in Estonia. International Journal of STD & Aids, 15 (10), 662−668.
 
Cowan, FM.; French, RS.; Mayaud, P.; Gopal, R.; Robinson, NJ.; de Oliveira, SA.; Faillace, T.; Uuskula, A.; Nygard-Kibur, M.; Ramalingam, S.; Sridharan, G.; El Aouad, R.; Alami, K.; Rbai, M.; Sunil-Chandra, NP.; Brown, DW. (2003). Seroepidemiological study of herpes simplex virus types 1 and 2 in Brazil, Estonia, India, Morocco, and Sri Lanka. Sexually Transmitted Infections, 79 (4), 286−290.
 
Uuskula, A.; Kohl, PK. (2002). Genital mycoplasmas, including Mycoplasma genitalium, as sexually transmitted agents. International Journal of STD & Aids, 13 (2), 79−85.
 
Uuskula, A.; Plank, T.; Lassus, A.; Bingham, JS. (2001). Sexually transmitted infections in Estonia - syndromic management of urethritis in a European country? International Journal of STD & AIDS, 12 (8), 493−498.
 
Wilson, TE.; Uuskula, A.; Feldman, J.; Holman, S.; Dehovitz, J. (2001). A case-control study of beliefs and behaviors associated with sexually transmitted disease occurrence in Estonia. Sexually Transmitted Diseases, 28 (11), 624−629.
 
Uuskula, A.; Silm, H.; Vessin, T. (1997). Sexually transmitted diseases in Estonia: Past and present. International Journal of STD & Aids, 8 (7), 446−450.
1.2. Teadusartiklid teistes rahvusvahelistes teadusajakirjades, millel on registreeritud kood, rahvusvaheline toimetus, rahvusvahelise kolleegiumiga eelretsenseerimine, rahvusvaheline levik ning kättesaadavus ja avatus kaastöödele
 
Low, N.; Redmond, S.; Uusküla, A.; van Bergen, J.; Ward, H.; Andersen, B.; Götz, H. (2013). Screening for genital chlamydia infection. Cochrane Database of Systematic Reviews, 12, x−x.10.1002/14651858.CD010866.
 
Des Jarlais DC, Pinkerton S, Hagan H, Guardino V, Feelemyer J, Cooper H, Hatzatkis A, Uuskula A. (2013). 30 Years on Selected Issues in the Prevention of HIV among Persons Who Inject Drugs. Advances in Preventive Medicine, 2012, 346372.
 
Rüütel, Kristi; Loit, Helle-Mai; Sepp, Tiiu; Kliiman, Kai; McNutt, Louise-Anne; Uusküla, Anneli. (2011). Enhanced tuberculosis case detection among substitution treatment patients: a randomized controlled trial. BMC Research Notes, 192.
 
Paat, G. ; Uusküla, A.; Tefanova, V.; Tallo, T.;Priimägi, L.;Ahi, K. (2009). The trends and risk factors for hepatitis B occurrence in Estonia. Central European Journal of Public Health, 17, 108−111.
 
Rüütel, K, Pisarev, H, Loit, HM, Uusküla, A. (2009). Factors influencing quality of life of people living with HIV in Estonia: a cross-sectional survey. Journal of the International AIDS Society, 12, 13.
 
Rüütel K, Uusküla A, Minossenko A, Loit HM (2008). Quality of life of people living with HIV and AIDS in Estonia. Central European Journal of Public Health, 16 (3), 111−115.
 
Uusküla, A.; Kalikova, N.; Zilmer, K.; Tammai, L.; DeHovitz, J. (2002). The role of injecting drug use in the emergence of HIV in Estonia. International Journal of Infectious Diseases, 6 (1), 23−27.
1.3. Eelretsenseeritud teadusartiklid Eesti ja teiste riikide eelretsenseeritavates teadusajakirjades, millel on kohalik toimetuskolleegium, või eelretsenseeritud teadusartiklid Eesti kultuurile olulistes ajakirjades või teadusartiklid ajakirjades Akadeemia, Looming ja Vikerkaar.
 
Anderson, Eva; Toompere, Karolin; Reile, Rainer; Uusküla, Anneli (2013). Naiste teadlikkus emakakaelavähki ennetavatest meetmetest Eestis 2011. aastal. Eesti Arst, 92 (4), 195−203.
 
Uusküla, A (2013). Ajas muutuvad eesmärgid. Eesti Arst, 92 (5), 244−246.
 
Uusküla, A. (2011). KONSTANDID NÕUAVAD TÄHELEPANU. Akadeemia, 1, 144−152.
 
Saava, Astrid;Puur, Allan;Altmets, Katre;Sakkeus, Luule;Uusküla, Anneli (2011). Toimetulekupiiranguid põhjustanud vigastused Eestis: rahvastikupõhine sündmuslooline uuring. Eesti Arst, 90, 4, 165−173.
 
Uusküla, A.; Jürisson, M.; Võrk, A.; Kallikorm, R. (2009). Sõeluuringu rakendamise põhjendatus osteoporoosi varaseks diagnoosimiseks Eestis. Eesti Arst, 402−413.
 
Altmets, K.; Katus, K.; Puur, A.; Saava, A.; Uusküla, A. (2008). Toimetulekupiirangud Eesti täisealises rahvastikus - levimus ja tegelik abistamine. Eesti Arst, 87 (2), 92−101.
 
Kangur, A.; Põder, A.; Maimets, M.; Silm, H.; Kukk, T.; Uusküla, A.; Rajangu, H.; Brilene, T.; Zilmer, K.; Saarma, I.; Karro, H.; Tammemäe, L.; Szirko, F.; Timberg, G.; Punab, M.; Kallikorm, R. (2007). Seksuaalsel teel levivate infektsioonide Eesti ravijuhend 2007. I. Omandatud süüfilis. Eesti Arst, 86 (10), 770−777.
 
Uusküla, A. (2004). Sugulisel teel levivad infektsioonid ja nende ravi HIV-infektsiooni ennetuses. Eesti Arst, 83 (3), 186−191.
 
Ahas, R.; Roosaare, J.; Uusküla, A.; Silm, S. (2004). Eestlaste sündide aastaajalisusest. Akadeemia, 12, 2563−2589.
 
Uusküla, A.; Silm, H. (2000). Genitaalsed mükoplasmainfektsioonid. Eesti Arst, 5, 282−286.
2.5. Projekti, tellitud teadustöö või analüüsi publitseeritud raport
 
Rooväli, L.; Pisarev, H.; Suija, K.; Aksen, M.; Uusküla, A.; Kiivet; RA: (2018). Aastatel 2006–2016 enesetapu sooritanute epidemioloogiline ülevaade.
 
Jürisson, Mikk; Taba, Pille; Võrno, Triin; Abram, Mikk; Eiche, Ivar-Endrik; Uusküla, Anneli (2015). Puukentsefaliidivastase vaktsineerimise kulutõhusus Eestis. Tartu: Tartu Ülikooli tervishoiu instituut.
 
Männik, Agnes; Suuroja, Tiit; Juus, Eva; Võrno, Triin; Uusküla, Anneli; Reile, Rainer; Orav, Kateriine; Kiivet, Raul-Allan (2014). Kolorektaalvähi sõeluringu kulutõhusus. 1−113.
 
Lõhmus, L.; Lemsalu, L.; Rüütel, K.; Laisaar, K.-T.; Uusküla, A. (2014). Infektsionisti külastavate HIV-i nakatunud inimeste tervis. 2013. aasta terviseuuringu raport.
 
Briljene, T.; Haldre, K.; Karro, H.; Konno, P.; Kukk, T.; Maimets, M.; Punab, M.; Põder, A.; Silm, H.; Szirko, F.; Sõritsa, A.; Zilmer, K.; Tamm, T.; Tammemäe, L.; Timberg, G.; Uusküla, A. (2011). Seksuaalsel teel levivate infektsioonide ravijuhised Eestis.
 
Liiv, Kristi; Lutsar, Katrin; Palm, Eva; Uusküla, Anneli; Kiivet, Raul-Allan (2011). Inimese papilloomiviiruse vastaste vaktsiinide kulutõhusus Eestis. Tartu: Tartu Ülikool, tervishoiu instituut.
3.1. Artiklid/peatükid lisas loetletud kirjastuste välja antud kogumikes (kaasa arvatud Web of Science Book Citation Index, Web of Science Conference Proceedings Citation Index, Scopus refereeritud kogumikud)
 
Uusküla, A. (2002). Genital infection with Herpes simplex virus. Skin and Environment - Perception and Protection: 10th EADV Congress; Munich, Germany; October 10-14, 2001. Ed. J.Ring, S.Weidinger, U.Darsow. Bologna: Monduzzi Editore, 321−328.
3.2. Artiklid/peatükid lisas mitte loetletud kirjastuste välja antud kogumikes
 
Lioznov D, Rüütel K, Uusküla A, DeHovitz J (2011). AIDS in Eastern Europe and Central Asia. In: Hall JC, Hall BJ, Cockerell CJ (Ed.). HIV/AIDS IN THE POST-HAART ERA: Manifestations, Treatment & Epidemiology (820). . P. Lang.
 
Ahas, R.; Roosaare, J.; Uusküla, A.; Silm, S. (2008). Seasonal variability of human reproduction in Estonia. In: Roosaare, J.; Mander, Ü. (Ed.). Estonia. Geographical Studies (19−41). . Tartu: Tartu Ülikooli Kirjastus. (Publicationes Instituti Geographici Universitatis Tartuensis; 107).
3.3. Spetsiifilised teadusväljaanded (sõnaraamatud, leksikonid, atlased, määrajad, tekstikriitilised väljaanded);
 
Põder, A.; Maimets, M.; Silm, H.; Kangur, A.; Kukk, T.; Uusküla, A.; Rajangu, H. (2003). Seksuaalsel teel levivate infektsioonide ravijuhis Eestis. Tallinn: STLIEÜ.
 
Napritson, K.; Raudsepp, H.; Uusküla, A.; Kukk, T.; Kangur, A.; Karelson, M.; Lehtmets, A.; Rajangu, H.; Silm, H. (2001). Akne ravijuhend. Lege Artis (24−26).. Tallinn: Lege Artis.
3.4. Artiklid/ettekanded, mis on avaldatud valdkonda 3.1. mittekuuluvates konverentsikogumikes
 
Laisaar, Kaja-Triin; Raag, Mait; Rasva, Heli; Uusküla, Anneli (2014). Engagement in the continuum of HIV care in Estonia. 337.
3.5. Artiklid/ettekanded, mis on avaldatud kohalikes konverentsikogumikes
 
Uusküla, A. (2002). Uretriit - diagnostika ja ravi. Seksuaalsel Teel Levivate Infektsioonide Eesti Ühingu Toimetised: STLIEÜ IV aastakonverents; 14-15.juuni 2002; Palmse mõis. 49.
5.1. Konverentsiteesid, mida kajastab Thomson Reuters Web of Science
 
Uusküla, Anneli; Laisaar, Kaja-Triin; Raag, Mait; Šmidt, Jelena; Semjonova, Svetlana; Kogan, Juta; Amico, K. Rivet; Sharma, Anjali; DeHovitz, Jack (2012). Antiretroviral therapy (ART) adherence and correlates to non-adherence among people on ART in Estonia. Retrovirology: 17th International Symposium on HIV and Emerging Infectious Diseases (ISHEID); 23-25 May 2012; Marseille, France. Biomed Central Ltd, P80. (9(Suppl 1)). DOI: 10.1186/1742-4690-9-S1-P80.
 
Laisaar, Kaja-Triin; Uusküla, Anneli, Sharma, Anjali; DeHovitz, Jack (2010). Services integration for injection drug users on antiretroviral therapy for management of HIV epidemic in Estonia. Retrovirology: 16th International Symposium on HIV and Emerging Infectious Diseases; 24-26 March 2010; Marseille, France. Biomed Central Ltd, P142. (7(Suppl 1)). DOI: 10.1186/1742-4690-7-S1-P142.
 
Altmets, K.; Katus, K.; Puur, A.; Saava, A.; Uusküla, A. (2008). Activity limitations among adult population: evidence of Estonian family and fertility survey. European Population Conference 2008. Programme and Abstracts: European Population Conference 2008. Migration and Migrants in Europe; Barcelona, Spain; 9-12.07.2008. European Association for Population Studies in association with Centre d`Estudis Demogràfics, 355−355.
5.2. Konverentsiteesid, mis ei kuulu valdkonda 5.1
 
Rooväli,L.; Pisarev,H.; Suija,K.; Uusküla,A.; Kiivet R-A. (2019). Aastatel 2006–2016 enesetapu sooritanute epidemioloogiline ülevaade. Eesti Arst, 98: Tartu Ülikooli arstiteaduskonna aastapäeva teaduskoneverents 2019. Tartu: Celsius Healthcare , 32−32. (lisa 3).
 
Rooväli,L.; Pisarev,H.; Suija,K.; Uusküla,A.; Kiivet R-A. (2019). Understanding risk factors and warning signs for suicide. In: .
 
Lemsalu L, Rice B, Uusküla A, Raag M, Lutsar I, Rüütel K (2018). How to ascertain an accurate number of people living with diagnosed HIV and fill data gaps from the past - lessons learned from a high prevalence setting in Europe. 22nd International AIDS Conference, Amsterdam, the Netherlands, 23-27 July 2018. International AIDS Society.
 
Lemsalu L, Uusküla A, Rice B, Raag M, Rüütel K (2018). Drug overdose is the most common cause of death among HIV infected people in Estonia. 22nd International AIDS Conference, Amsterdam, the Netherlands, 23-27 July 2018. International AIDS Society.
 
Laisaar, Kaja-Triin; Raag, Mait; Lemsalu, Liis; Lõhmus, Liilia; Rüütel, Kristi; Amico, K. Rivet; Uusküla, Anneli; and the HIV-BRIDGE Study Group (2017). Patient characteristics to consider when supporting antiretroviral therapy adherence in people living with HIV: a randomized controlled trial in Estonia. Conference Abstract Book: 12th International Conference on HIV Treatment and Prevention Adherence (ADHERENCE 2017); Miami, FL, USA: 04.-06.06.2017. International Association of Providers of AIDS Care (IAPAC), 84−84.
 
Lemsalu, L., Rüütel, K., Lõhmus, L., Laisaar, KT., Uusküla, A., for OptTEST by HIV in Europe (2016). Changes in quality of life of PLHIV in Estonia from 2005 to 2013. 21st International AIDS Conference, Durban, South Africa, July 18-22, 2016. International AIDS Society, 143.
 
Jõgeda, Ene-Ly; Avi, Radko; Pauskar, Merit; Kallas, Eveli; Karki, Tõnis; Jarlais, Don Des; Uusküla, Anneli; Lutsar, Irja; Huik, Kristi; (2015). HTLV-1/2 is rare among Eastern-European intravenous drug users (IDUs). Retrovirology, 12, P79−P79. DOI: doi.org/10.1186/1742-4690-12-S1-P79.
 
Laisaar, K.T., Raag, M., Rüütel, K., Lemsalu, L., Lõhmus, L., Uusküla, A. (2015). Measuring Antiretroviral Therapy Adherence in Clinical Care Settings in Estonia. 10th International Conference on HIV Treatment and Prevention Adherence, Miami, USA, June 28-30 2015. International Association of Providers of AIDS Care, 103.
 
Lemsalu, L., Rüütel, K., Lõhmus, L., Laisaar, K-T., Uusküla, A. (2014). Suicidality is common among HIV infected people in Estonia and is associated with lack of psychological help. 15th European Symposium on Suicide and Suicidal Behaviour, Tallinn, Estonia, 27-30.08.2014. European Symposium on Suicide and Suicidal Behaviour, 280.
 
Jõgeda, Ene-Ly; Huik, Kristi; Pauskar, Merit; Kallas, Eveli; Krispin, Tõnu; Karki, Tõnis; Marsh, Kristina; Des Jarlais, Don; Uusküla, Anneli; Avi, Radko; Lutsar, Irja. (2013). The prevalence of GBV-C and its associations with HIV infection among Estonian intravenous drug users. Reviews in Antiviral Therapy Infectious Diseases: 11th European Meeting on HIV & Hepatitis- Treatment Strategies & Antiviral Drug Resistance; Rome; 20-22 March 2013. , 46−47.
 
Raag, Mait; Uusküla, Anneli; Des Jarlais, Don; Wiessing, Lucas (2013). Relationship between risk behaviour and awareness of HIV status among injecting drug users: a multisite study. European Journal of Epidemiology, 28: European Congress on Epidemiology 2013, Aarhus, Taani, 2013. Springer, S195−S196.
 
Uibopuu, H.; Huik, K.; Avi, R.; Pauskar, M.; Kallas, E.; Karki, T.; Krispin, T.; Kool, P.; Schmidt, J.; Rüütel, K.; Talu, A.; Abel-Ollo, K.; Uusküla, A.; Lutsar, I. (2012). Viral tropism of HIV-1 CRF06_cpx and its association with CCR5 haplotypes. 10th European Meeting on HIV & Hepatitis - Treatment Strategies & Antiviral Drug Resistance, 28 - 30 March 2012 Barcelona Spain.
 
Sadam, M.; Karki, T.; Huik, K.; Avi, R.; Rüütel, K.; Uusküla, A.; Lutsar, I (2008). CCL3L1 Variable Gene Copy Number Influence on the Susceptibility to HIV-1/AIDS Among Estonian Intravenous Drug User. The 15th Conference on Retroviruses and Opportunistic Infections (CROI), Boston, 03.02-06.02.2008.
 
Altmets K., Katus K., Puur A., Saava A., Uusküla A. (2007). Toimetulekupiirangute levimus Eesti täisealises rahvastikus. Eesti Arst, 86. Eesti Arst, 679−680. (9).
6.6. Muudes ajakirjades ja ajalehtedes avaldatud artiklid;
 
Põder, A.; Uusküla, A.; Vendirevskih, G.; Silm, H.; Raukas, E.; Brilene, T. (1999). Meeste uretriidi ja naiste endotservitsiidi/kolpiidi etioloogiline struktuur Eestis. Eesti Naistearstide Seltsi Teataja, 9, 36−41.
6.8. Lühikirjutised teadusajakirjades ja kogumikes
 
Veerus, Piret; Salumets, Andres; Naaber, Paul; Krjutškov, Kaarel; Tilk, Kadi; Laanpere, Made; Uusküla, Anneli (2020). Seroprevalence of SARS-CoV-2 antibodies among pregnant women in Estonia: A call for epidemiological studies. Acta Obstetricia Et Gynecologica Scandinavica, 99 (12), 1736−1737. DOI: 10.1111/aogs.13995.
 
Uusküla, Anneli; Jarlais, Don Des; Vorobjov, Sigrid (2019). The fentanyl epidemic in Estonia: opportunities for a comprehensive public health response. The Lancet Psychiatry, 6 (12), 985−985. DOI: 10.1016/S2215-0366(19)30436-5.
21.07.2022

Anneli Uusküla

https://www.etis.ee/CV/Anneli_Uusküla001/eng
11.04.1967
737 4195
anneli.uuskula@ut.ee
http://
H-3303-2015

Career

Institutions and positions
01.02.2018–...   
University of Tartu, Faculty of Medicine, Institute of Family Medicine and Public Health, Professor (1,00)
2007–...   
Department of Family Medicine and Public Health, Professor (1,00)
2000–...   
Tartu University Hospital, Dermatology Clinic of Tartu University Hospital, Dermatovenerologist (0,25)
01.01.2016–31.01.2018   
University of Tartu, Faculty of Medicine, Institute of Family Medicine and Public Health, Programme Director
01.01.2016–31.01.2018   
University of Tartu, Faculty of Medicine, Institute of Family Medicine and Public Health, Professor of Epidemiology (1,00)
01.02.2013–31.12.2015   
University of Tartu, Faculty of Medicine, Dean's Office, Programme Director
01.02.2013–31.12.2015   
University of Tartu, Faculty of Medicine, Department of Public Health, Professor of Epidemiology (1,00)
01.02.2008–31.01.2013   
University of Tartu, Faculty of Medicine, Department of Public Health, Professor of Epidemiology (1,00)
01.02.2008–28.02.2009   
University of Tartu, Faculty of Medicine, Department of Public Health, Head of Institute
01.03.2007–31.01.2008   
University of Tartu, Faculty of Medicine, Department of Public Health, Professor extraordinarius (0,50)
01.03.2007–31.01.2008   
University of Tartu, Faculty of Medicine, Department of Public Health, Head of Institute
01.03.2007–31.01.2008   
University of Tartu, Faculty of Medicine, Department of Public Health, Senior Research Fellow (0,50)
01.02.2007–28.02.2007   
University of Tartu, Faculty of Medicine, Department of Public Health, Acting Head of Institute
2007–2009   
University of Tartu, Faculty of Medicine, Department of Public Health, Chair (0,25)
01.01.2005–28.01.2007   
University of Tartu, Faculty of Medicine, Department of Dermatology, Senior Assistant (0,25)
01.05.2004–28.02.2007   
University of Tartu, Faculty of Medicine, Department of Public Health, Senior Research Fellow (0,75)
 
 
Education
2001–2003   
2001-2003 State University of New York, University at Albany, School of Public Health, MSc epidemiology
1997–2001   
1997-2001 Tartu University Medical Doctorancy (degree of Doctor of Medical Sciences)
1993–1997   
1993-1997 Tartu University Clinic of Dermatovenerology, Medical Residency in Dermatovenerology
1991–1993   
1991-1993 Tartu University Medical Internship [1993, Clinician, Department of Obstetrics and Gynecology; 1992, Clinician, Department of Internal Medicine; 1991, Clinician, Department of Surgery]
1985–1991   
1985-1991 Tartu University Medical Faculty
 
 
R&D related managerial and administrative work
2019−...   
Estonian Research Council, health area expert committee, member
2013−...   
Journal BMC infectious diseases, editor
2012−...   
Estonian clinical and patient guidelines council, member
2011−...   
Journal Eesti arst, scientific editor
2009−...   
European Center of Disease Control (ECDC), expert
2007−...   
Estonian health insurance fund, public health commission, member
2007−...   
European Social Survey (Estonia), chairman of the board
2005−...   
European Medicines Agency, EMEA, expert
1999−...   
State agency of medicines, expert (dermatology)
1997−...   
Member of New York Academy of Sciences
2006−2018   
Society of dermatovenerologists in Estonia (President)until 2012, member of the Board 2012-2018
2004−2008   
European Surveillance of Sexually Transmitted Infections (ESSTI), country representative
1999−2010   
Union against sexually transmitted infections in Estonia (member of board)
 
 
Additional information
COMPLETED RESEARCH GRANTS

National institutes of health (USA)/NIAID R01AI083035
06/2009-08/2014
PI - DesJarlais D (Beth Isreal Med Center, NY, USA)
Multiple Prevention Programs Project for IDUs in Eastern Europe (Estonia)

European Commission/ Leonardo da Vinci Programme
01/2013-12/2015
PI – McNulty C (HPA, UK)
Chlamydia Testing Training Into Europe (CaTTE)

European Centre for Disease Prevention and Control (ECDC)
01/2012-04/2014
PI – Low N (Univ Bern, Switzerland)
Chlamydia Control in Europe

Norwegian Financial Mechanism / EEA grant EE0016
11/2007 – 05/2011
PI – Uusküla A/Kiivet R
Capacity building for disease surveillance and health monitoring in Estonia

National institutes of health (USA) / FIC R01 TW06990-01
07/2004-07/2010
PI - Uuskula A
Homescreening for sexually transmitted infections in Estonia

Merck (USA) Investigator initiated research program MISP #38078
12/2010-12/2013
PI – Uusküla A (Univ Tartu)
The Burden of Genital Warts: a study from three Baltic countries

National institutes of health (USA) / NIDA R01 003574
09/2005 - 08/2010
PI - Des Jarlais DC
Risk Factors for AIDS among IV Drug Users

European Centre for Disease prevention and Control OJ/2008/04/11 – PROC/2008/006
06/2008-05/2010
PI – Low N
Evaluating the public health benefits of partner notification

Civilian Research & Development Foundation (USA) ESB1-7002-TR-08
10/2008 - 12/2010
PI – Uusküla A
HIV Transmission Among Injecting and Non-Injecting Drug Users in Tallinn, Estonia

Civilian Research & Development Foundation (USA) ESXO-002722-TA06
PI - Uusküla A
Development of an Intervention/Prevention to Block Transmission from Injection Drug Users to Their Sex Partners.
02/2006-01/2008

Qualifications

Academic degrees
Anneli Uusküla, Research Master's Degree, 2003, (sup) Louise-Anne McNutt, Treatment of the sexually transmitted diseases in Estonia: consistency with the evidence based medicine principles, State University of New York at Albany, School of Public Health.
Anneli Uusküla, Doctor's Degree, 2001, (sup) Helgi Silm, Epidemiology of sexually transmitted diseases in Estonia in 1990 - 2000, University of Tartu, Faculty of Medicine.
 
 
Honours & awards
2001, Anneli Uusküla, NIH Fellowship, Fogarty International Center (2001-2003)
 
 
Fields of research
ETIS RESEARCH FIELD: 3. Health; 3.6. Public Health Science
ETIS RESEARCH FIELD: 3. Health; 3.7. Clinical Medicine
 
 

Projects in progress

Completed projects

Dissertations under supervision

Supervised dissertations

Publications

 
1.1. Teadusartiklid, mis on kajastatud Web of Science andmebaasides Science Citation Index Expanded, Social Sciences Citation Index, Arts & Humanities Citation Index, Emerging Sources Citation Index ja/või andmebaasis Scopus (v.a. kogumikud)
 
Uusküla, A.; Kalda, R.; Solvak, M.; Jürisson, M.; Käärik, M.; Fischer, K.; Keis, A.; Raudvere, U.; Vilo, J.; Peterson, H.; Käärik, E.; Metspalu, M.; Jürgenson, T.; Milani, L.; Kolberg, L.; Tiit, E.-M.; Vassil, K. (2022). The 1st year of the COVID-19 epidemic in Estonia: a population-based nationwide sequential/consecutive cross-sectional study. Public Health, 205, 150−156. DOI: 10.1016/j.puhe.2022.02.004.
 
Uuskula, Anneli; Jürgenson, Tuuli; Pisarev, Heti; Kolde, Raivo; Meister, Tatjana; Tisler, Anna; Suija, Kadri; Kalda, Ruth; Piirsoo, Marko; Fischer, Krista (2022). Long-Term Mortality Following COVID-19 Infection: A National Cohort Study From Estonia. SSRN Electronic Journal. DOI: 10.2139/ssrn.4028547.
 
Anneli Uusküla, Tuuli Jürgenson, Heti Pisarev, Raivo Kolde, Tatjana Meister, Anna Tisler, Kadri Suija, Ruth Kalda, Marko Piirsoo, Krista Fischer (2022). Long-term mortality following COVID-19 infection: a national cohort study from Estonia. The Lancet Regional Health - Europe, x, 100394. DOI: 10.1016/j.lanepe.2022.100394.
 
Uuskula, Anneli; Keis, Aime; Toompere, Karolin; Planken, Anu; Rebrov, Konstantin (2022). Cluster randomised, controlled, triple-blind trial assessing the efficacy of intranasally administered virus-neutralising bovine colostrum supplement in preventing SARS-CoV-2 infection in household contacts of SARS-CoV-2-positive individuals: a study protocol. Trials, 23 (1), ARTN 92. DOI: 10.1186/s13063-022-06039-9.
 
Uusküla A, Talu A, Rannap J, Barnes DM, Des Jarlais D. (2021). Rapid point-of-care (POC) testing for Hepatitis C antibodies in a very high prevalence setting: persons injecting drugs in Tallinn, Estonia. Harm Reduction Journal, 18 (1), 39. DOI: 10.1186/s12954-021-00485-5.
 
Wiessing L, Kalamara E, Stone J, ... Dolan K, Uusküla A, Vickerman P. (2021). Univariable associations between a history of incarceration and HIV and HCV prevalence among people who inject drugs across 17 countries in Europe 2006 to 2020 - is the precautionary principle applicable? Eurosurveillance, 26 (49). DOI: 10.2807/1560-7917.ES.2021.26.49.2002093.
 
Jürisson, Mikk; Pisarev, Heti; Uusküla, Anneli; Lang, Katrin; Oona, Marje; Elm, Lisanna; Kalda, Ruth (2021). Physical-mental health comorbidity: A population-based cross-sectional study. PLoS ONE, 16 (12), e0260464. DOI: 10.1371/journal.pone.0260464.
 
Jürisson, Mikk; Pisarev, Heti; Uusküla, Anneli; Lang, Katrin; Oona, M; Kalda, Ruth (2021). Prevalence of chronic conditions and multimorbidity in Estonia: a population-based cross-sectional study. BMJ Open, 11 (10), 1−7. DOI: 10.1136/bmjopen-2021-049045.
 
Des Jarlais, Don C.; Arasteh, Kamyar; Barnes, David M.; Feelemyer, Jonathan; Berg, Hayley; Raag, Mait; Talu, Ave; Org, Greete; Tross, Susan; Uuskula, Anneli (2021). A Multistage Process Model of How a Person Who Currently Injects Drugs Comes to Assist Persons Who Do not Inject with Their First Injections. Frontiers in Sociology, 6, ARTN 619560. DOI: 10.3389/fsoc.2021.619560.
 
Tisler, Anna; Ojavee, Sven Erik; Veerus, Piret; Soodla, Pilleriin; Uuskuela, Anneli (2021). Cervical cancer screening patterns among HIV-positive women in Estonia: a population-based retrospective cohort study. BMC Cancer, 21 (1), ARTN 350. DOI: 10.1186/s12885-021-08076-0.
 
Uusküla, Anneli; Raag, Mait; Kurvits, Katrin; Laius, Ott; Uusküla, Maia; Oselin, Kersti (2020). Trends in opioid prescribing in Estonia (2011-2017). Pharmacology Research & Perspectives, 8 (2), e00577−e00577. DOI: 10.1002/prp2.577.
 
Uuskula, Anneli; Talu, Ave; Vorobjov, Sigrid; Salekesin, Maris; Rannap, Jurgen; Lemsalu, Liis; Jarlais, Don Des (2020). The fentanyl epidemic in Estonia: factors in its evolution and opportunities for a comprehensive public health response, a scoping review. International Journal of Drug Policy, 81, ARTN 102757. DOI: 10.1016/j.drugpo.2020.102757.
 
Uusküla A, Vickerman P, Raag M, et al. (2020). Presenting a conceptual framework for an HIV prevention and care continuum and assessing the feasibility of empirical measurement in Estonia: A case study. PLoS ONE, 15 (10), e0240224. DOI: 10.1371/journal.pone.0240224.
 
Raag, Mait; Vorobjov, Sigrid; Uusküla, Anneli (2019). Prevalence of injecting drug use in Estonia 2010-2015: a capture-recapture study. Harm Reduction Journal, 16 (1), 19−19. DOI: 10.1186/s12954-019-0289-3.
 
Des Jarlais, Don; Uuskula, Anneli; Talu, Ave; Barnes, David M; Raag, Mait; Arasteh, Kamyar; Org, Greete; Demarest, Donna; Feelemyer, Jonathan; Berg, Hayley; Tross, Susan (2019). Implementing an Updated "Break the Cycle" Intervention to Reduce Initiating Persons into Injecting Drug Use in an Eastern European and a US "opioid epidemic" Setting. AIDS and Behavior, 23 (9), 2304−2314. DOI: 10.1007/s10461-019-02467-y.
 
Tavitian-Exley, Isabel; Maheu-Giroux, Mathieu; Platt, Lucy; Heimer, Robert; Uusküla, Anneli; Levina, Olga; Vickerman, Peter; Boily, Marie-Claude (2018). Differences in risk behaviours and HIV status between primary amphetamines and opioid injectors in Estonia and Russia. The International journal on drug policy, 53, 96−105.10.1016/j.drugpo.2017.11.010.
 
Werb, Dan; Bluthenthal, R. N.; Kolla, G.; Strike, C.; Kral, A. H.; Uuskula, A.; Des Jarlais, D. (2018). Preventing Injection Drug use Initiation: State of the Evidence and Opportunities for the Future. Journal of Urban Health, 95 (1), 91−98.10.1007/s11524-017-0192-8.
 
Chan, Pui Y; Joseph, Michael A; Des Jarlais, Don C; Uusküla, Anneli (2018). Perceived effectiveness of antiretroviral therapy, self-rated health and treatment adherence among HIV-positive people who inject drugs in Estonia. International Journal of STD & AIDS, 29 (1), 13−22. DOI: 10.1177/0956462417714635.
 
Uusküla, Anneli; Laisaar, Kaja-Triin; Raag, Mait; Lemsalu, Liis; Lõhmus, Liilia; Rüütel, Kristi; Amico, K. Rivet; HIV-BRIDGE Study Group (2018). Effects of Counselling on Adherence to Antiretroviral Treatment Among People with HIV in Estonia: A Randomized Controlled Trial. AIDS and Behavior, 22 (1), 224−233. DOI: 10.1007/s10461-017-1859-6.
 
Jõgeda, E-L; Avi, R; Pauskar, M; Kallas, E; Karki, T; Des Jarlais, D; Uusküla, A; Toompere, K; Lutsar, I; Huik, K (2018). Association of IFNλ4 rs12979860 polymorphism with the acquisition of HCV and HIV infections among people who inject drugs. Journal of Medical Virology, 90 (11), 1779−1783. DOI: 10.1002/jmv.25258.
 
Tavitian-Exley, Isabel; Boily, Marie-Claude; Heimer, Robert; Uuskula, Anneli; Levina, Olga; Maheu-Giroux, Mathieu (2018). Polydrug Use and Heterogeneity in HIV Risk Among People Who Inject Drugs in Estonia and Russia: A Latent Class Analysis. AIDS and Behavior, 22 (4), 1329−1340.10.1007/s10461-017-1836-0.
 
Tisler-Sala, Anna; Ojavee, Sven-Erik; Uuskula, Anneli (2018). Treatment of chlamydia and gonorrhoea, compliance with treatment guidelines and factors associated with non-compliant prescribing: findings form a cross-sectional study. Sexually Transmitted Infections, 94 (4), 297−302. DOI: 10.1136/sextrans-2017-053247.
 
Kivimets, Kristel; Uuskula, Anneli; Lazarus, Jeffrey V.; Ott, Kristi (2018). Hepatitis C seropositivity among newly incarcerated prisoners in Estonia: data analysis of electronic health records from 2014 to 2015. BMC Infectious Diseases, 18, ARTN 339. DOI: 10.1186/s12879-018-3242-2.
 
Uusküla, Anneli; Pisarev, Heti; Kurvits, Katrin; Laius, Ott; Laanpere, Made; Uusküla, Maia (2018). Compliance with Pregnancy Prevention Recommendations for Isotretinoin in Estonia in 2012-2016. Drugs - Real World Outcomes, 5 (2), 129−136. DOI: 10.1007/s40801-018-0135-z.
 
Des Jarlais, Don C.; Arasteh, K.; Feelemyer, J.; McKnight, C.; Barnes, David M.; Perlman, David C.; Uuskula, A.; Cooper, H. L. F.; Tross, Susan (2018). Hepatitis C virus prevalence and estimated incidence among new injectors during the opioid epidemic in New York City, 2000-2017: Protective effects of non-injecting drug use. Drug and Alcohol Dependence, 192, 74−79. DOI: 10.1016/j.drugalcdep.2018.07.034.
 
Uusküla, Anneli; Raag, Mait; Vorobjov, Sigrid; Des Jarlais, Don (2018). Another frontier for harm reduction: contraceptive needs of females who inject drugs in Estonia, a cross-sectional study. Harm Reduction Journal, 15, ARTN 10. DOI: 10.1186/s12954-018-0215-0.
 
Uuskula, Anneli; Barnes, David M.; Raag, Mait; Talu, Ave; Tross, Susan; Des Jarlais, Don C. (2018). Frequency and factors associated with providing injection initiation assistance in Tallinn, Estonia. Drug and Alcohol Dependence, 188, 64−70. DOI: 10.1016/j.drugalcdep.2018.03.048.
 
Johannson A, Vorobjov S, Heimer R, Dovidio JF, Uusküla A. (2017). The Role of Internalized Stigma in the Disclosure of Injecting Drug Use Among People Who Inject Drugs and Self-Report as HIV-Positive in Kohtla-Järve, Estonia. AIDS and Behavior, 21 (4), 1034−1043. DOI: 10.1007/s10461-016-1647-8.
 
Anneli Uusküla, Mait Raag, Kristina Marsh, Ave Talu, Sigrid Vorobjov, Don Des Jarlais (2017). HIV prevalence and gender differences among new injection-drug-users in Tallinn, Estonia: A persisting problem in a stable high prevalence epidemic. PLoS ONE, 12 (2), e0170956. DOI: 10.1371/journal.pone.0170956.
 
Jogeda, Ene-Ly; Huik, Kristi; Pauskar, Merit; Kallas, Eveli; Karki, Tonis; Jarlais, Don Des; Uuskula, Anneli; Lutsar, Irja; Avi, Radko (2017). Prevalence and Genotypes of GBV-C and Its Associations With HIV Infection Among Persons Who Inject Drugs in Eastern Europe. Journal of Medical Virology, 89 (4), 632−638. DOI: 10.1002/jmv.24683.
 
Wu, Jiacheng; Crawford, Forrest W; Raag, Mait; Heimer, Robert; Uusküla, Anneli (2017). Using data from respondent-driven sampling studies to estimate the number of people who inject drugs: Application to the Kohtla-Järve region of Estonia. PLoS ONE, 12 (11), e0185711−e0185711.10.1371/journal.pone.0185711.
 
Mikk Jürisson, Mait Raag, Riina Kallikorm, Margus Lember, Anneli Uusküla (2017). The impact of hip fracture on mortality in Estonia: a retrospective population-based cohort study. BMC Musculoskeletal Disorders, 18 (243), 1−10. DOI: 10.1186/s12891-017-1606-1.
 
Võrno, Triin; Lutsar, Katrin; Uusküla, Anneli; Padrik, Lee; Raud, Terje; Reile, Rainer; Nahkur, Oliver; Kiivet, Raul-Allan (2017). Cost-effectiveness of HPV vaccination in the context of high cervical cancer incidence and low screening coverage. Vaccine, 35 (46), 6329−6335. DOI: 10.1016/j.vaccine.2017.08.083.
 
Heimer, Robert; Usacheva, Nina; Barbour, Russell; Niccolai, Linda M; Uusküla, Anneli; Levina, Olga S (2017). Engagement in HIV care and its correlates among people who inject drugs in St Petersburg, Russian Federation and Kohtla-Järve, Estonia. Addiction, 112 (8), 1421−1431. DOI: 10.1111/add.13798.
 
McNulty C, Ricketts EJ, Fredlund H, Uusküla A, Town K, Rugman C, Tisler-Sala A, Mani A, Dunais B, Folkard K, Allison R, Touboul P. (2017). Qualitative interviews with healthcare staff in four European countries to inform adaptation of an intervention to increase chlamydia testing. BMJ Open, 7 (9), e017528. DOI: 10.1136/bmjopen-2017-017528.
 
Wiessing, Lucas; Ferri, Marica; Běláčková, Vendula; Carrieri, Patrizia; Friedman, Samuel R; Folch, Cinta; Dolan, Kate; Galvin, Brian; Vickerman, Peter; Lazarus, Jeffrey V; Mravčík, Viktor; Kretzschmar, Mirjam; Sypsa, Vana; Sarasa-Renedo, Ana; Uusküla, Anneli; Paraskevis, Dimitrios; Mendão, Luis; Rossi, Diana; van Gelder, Nadine; Mitcheson, Luke ... Griffiths, Paul (2017). Monitoring quality and coverage of harm reduction services for people who use drugs: a consensus study. Harm Reduction Journal, 14 (1), 19−19. DOI: 10.1186/s12954-017-0141-6.
 
Lemsalu, L.; Rüütel, K.; Laisaar, KT.; Lõhmus, L.; Raidvee, A.; Uusküla, A.; HIV-BRIDGE Study Group (2017). Suicidal Behavior Among People Living with HIV (PLHIV) in Medical Care in Estonia and Factors Associated with Receiving Psychological Treatment. AIDS and Behavior, 21 (6), 1709−1716. DOI: 10.1007/s10461-016-1561-0.
 
Huik, Kristi; Avi, Radko; Pauskar, Merit; Kallas, Eveli; Jõgeda, Ene-Ly; Karki, Tõnis; Rüütel, Kristi; Talu, Ave; Abel-Ollo, Katri; Uusküla, Anneli; Carrillo, Andrew; Ahuja, Sunil K; He, Weijing; Lutsar, Irja (2016). A CCL5 Haplotype Is Associated with Low Seropositivity Rate of HCV Infection in People Who Inject Drugs. PLoS ONE, 11 (6), e0156850−e0156850. DOI: 10.1371/journal.pone.0156850.
 
van den Broek, Ingrid V.; Sfetcu, Otilia; van der Sande, Marianne A.; Andersen, Berit; Herrmann, Björn; Ward, Helen; Götz, Hannelore M.; Uusküla, Anneli; Woodhall, Sarah C.; Redmond, Shelagh M.; Amato-Gauci, Andrew J.; Low, Nicola; van Bergen, Jan E. (2016). Changes in chlamydia control activities in Europe between 2007 and 2012: a cross-national survey. European Journal of Public Health, 26 (3), 382−388. DOI: 10.1093/eurpub/ckv196.
 
Calabrese, Sarah K.; Burke, Sara E.; Dovidio, John F.; Levina, Olga S.; Uusküla, Anneli; Niccolai, Linda M.; Heimer, Robert (2016). Internalized HIV and Drug Stigmas: Interacting Forces Threatening Health Status and Health Service Utilization Among People with HIV Who Inject Drugs in St. Petersburg, Russia. AIDS and Behavior, 20 (1), 85−97. DOI: 10.1007/s10461-015-1100-4.
 
Low, N.; Redmond, S.; Uusküla, A.; van Bergen, J.; Ward, H.; Andersen, B.; Götz, H. (2016). Screening for genital chlamydia infection. Cochrane Database of Systematic Reviews, 2016 (9), Article number CD010866. DOI: 10.1002/14651858.CD010866.pub2.
 
Jürisson, Mikk; Pisarev, Heti; Kanis, John; Borgström, Fredrik; Svedbom, Axel; Kallikorm, Riina; Lember, Margus; Uusküla, Anneli (2016). Quality of life, resource use, and costs related to hip fracture in Estonia. Osteoporosis International, 27 (8), 2555−2566. DOI: 10.1007/s00198-016-3544-4.
 
Kallas, Eveli; Huik, Kristi; Türk, Silver; Pauskar, Merit; Jõgeda, Ene-Ly; Šunina, Marina; Karki, Tõnis; Des Jarlais, Don; Uusküla, Anneli; Avi, Radko; Lutsar, Irja (2016). Differences in T cell distribution and CCR5 expression in HIV-positive and HIV-exposed seronegative persons who inject drugs. Medical Microbiology and Immunology, 205 (3), 231−239. DOI: 10.1007/s00430-015-0444-8.
 
Jõgeda, Ene-Ly; Avi, Radko; Pauskar, Merit; Kallas, Eveli; Karki, Tõnis; Des Jarlais, Don; Uusküla, Anneli; Lutsar, Irja; Huik, Kristi (2016). Human T-lymphotropic virus types 1 and 2 are rare among intravenous drug users in Eastern Europe. Infection Genetics and Evolution, 43, 83−85. DOI: 10.1016/j.meegid.2016.05.022.
 
Kallas, Eveli; Huik, Kristi; Türk, Silver; Pauskar, Merit; Jõgeda, Ene-Ly; Šunina, Marina; Karki, Tõnis; Des Jarlais, Don; Uusküla, Anneli; Avi, Radko; Lutsar, Irja (2016). T Cell Distribution in Relation to HIV/HBV/HCV Coinfections and Intravenous Drug Use. Viral Immunology, 0−0. DOI: 10.1089/vim.2016.0057.
 
Laisaar, K.T.; Raag, M.; Lutsar, I.; Uusküla, A. (2016). People living with HIV in Estonia: engagement in HIV care in 2013. Eurosurveillance, 21 (43), x−x. DOI: 10.2807/1560-7917.ES.2016.21.43.30380.
 
Uusküla, Anneli; Reile, Rainer; Rezeberga, Dace; Karnite, Anda; Logminiene, Zenetha; Padaiga, Zilvinas; Nygård, Mari. (2015). The prevalence of genital warts in the Baltic countries: findings from national cross-sectional surveys in Estonia, Latvia and Lithuania. Sexually Transmitted Infections, 91 (1), 55−60. DOI: 10.1136/sextrans-2014-051540.
 
Shelagh M. Redmond, Karin Alexander-Kisslig, Sarah C. Woodhall, Ingrid V. F. van den Broek, Jan van Bergen, Helen Ward, Anneli Uusküla, Björn Herrmann, Berit Andersen, Hannelore M. Götz, Otilia Sfetcu, Nicola Low (2015). Genital Chlamydia prevalence in europe and non-European high income countries: systematic review and meta-analysis. PLoS ONE, 10 (1), e0115753. DOI: 10.1371/journal.pone.0115753.
 
Uusküla, A.; Erm, T. (2015). Disseminated Giant Hyperkeratotic Porokeratosis and Treatment with Acitretin: A Case Report. Acta Dermato Venereologica, 95 (2), 241−242. DOI: 10.2340/00015555-1908.
 
Feelemyer, J.; Des Jarlais, D.; Arasteh, K.; Uusküla, A. (2015). Adherence to Antiretroviral Medications Among Persons Who Inject Drugs in Transitional, Low and Middle Income Countries: An International Systematic Review. AIDS and Behavior, 19 (4), 575−583.10.1007/s10461-014-0928-3.
 
Perlman DC, Jordan AE, Uuskula A, Huong DT, Masson CL, Schackman BR, Des Jarlais DC. (2015). An international perspective on using opioid substitution treatment to improve hepatitis C prevention and care for people who inject drugs: Structural barriers and public health potential. International Journal of Drug Policy, S0955-3959(15)00126-7.
 
Uusküla, A.; Des Jarlais, D.C.; Raag, M.; Pinkerton, S.D.; Feelemyer, J. (2015). Combined prevention for persons who inject drugs in the HIV epidemic in a transitional country: the case of Tallinn, Estonia. AIDS Care, 27 (1), 105−11. DOI: 10.1080/09540121.2014.940271.
 
Jürisson, Mikk; Vorobjov, Sigrid; Kallikorm, Riina; Lember, Margus; Uusküla, Anneli. (2015). The incidence of hip fractures in Estonia, 2005–2012. Osteoporosis International, 26 (1), 77−84. DOI: 10.1007/s00198-014-2820-4.
 
Morozova, Olga; Levina, Olga; Uusküla, Anneli; Heimer, Robert (2015). Comparison of subset selection methods in linear regression in the context of health-related quality of life and substance abuse in Russia. BMC Medical Research Methodology, 15 (71), 71−71.10.1186/s12874-015-0066-2.
 
Burke, Sara E.; Calabrese, Sarah K.; Dovidio, John F.; Levina, Olga S.; Uusküla, Anneli; Niccolai, Linda M.; Abel-Ollo, Katri; Heimer, Robert (2015). A tale of two cities: Stigma and health outcomes among people with HIV who inject drugs in St. Petersburg, Russia and Kohtla-Järve, Estonia. Social Science & Medicine, 130, 154−161. DOI: 10.1016/j.socscimed.2015.02.018.
 
Laisaar, Kaja-Triin; Raag, Mait; Rosenthal, Marika; Uusküla, Anneli (2015). Behavioral Interventions to Reduce Sexual Risk Behavior in Adults with HIV/AIDS Receiving HIV Care: A Systematic Review. AIDS Patient Care and STDs, 29 (5), 288−289. DOI: 10.1089/apc.2014.0240.
 
Uuskuela, Anneli; Raag, Mait; Vorobjov, Sigrid; Rueuetel, Kristi; Lyubimova, Alexandra; Levina, Olga S.; Heimer, Robert (2015). Non-fatal overdoses and related risk factors among people who inject drugs in St. Petersburg, Russia and Kohtla-Jarve, Estonia. BMC Public Health, 15, ARTN 1255. DOI: 10.1186/s12889-015-2604-6.
 
Uusküla, A.; Toompere, K.; Laisaar, KT.; Rosenthal, M.; Pürjer, ML.; Knellwolf, A.; Läärä, E.; Des Jarlais, DC. (2015). HIV research productivity and structural factors associated with HIV research output in European Union countries: a bibliometric analysis. BMJ Open, 5 (2), e006591−8. DOI: 10.1136/bmjopen-2014-006591.
 
Kivimets K, Uuskula A. (2014). HIV testing and counselling in Estonian prisons, 2012 to 2013: aims, processes and impacts. Eurosurveillance, 19 (47), 31−37.
 
Uusküla A, Ricketts EJ, Rugman C, Kalda RR, Fredlund H, Hedlund J, Dunais B, Touboul PP, McNulty C (2014). Provision of chlamydia testing, and training of primary health care staff about chlamydia testing, across four European countries. BMC Public Health, 14, 1147.10.1186/1471-2458-14-1147.
 
DeHovitz, J.; Uuskula, A.; El-Bassel, N. (2014). The HIV epidemic in Eastern Europe and Central Asia. Current HIV/AIDS Reports, 11 (2), 168−176.10.1007/s11904-014-0202-3.
 
Huik, K.; Avi, R.; Uibopuu, H.; Pauskar, M.; Margus, T.; Karki, T.; Krispin, T.; Kool, P.; Rüütel, K.; Talu, A.; Abel-Ollo, K.; Uusküla, A.; Carrillo, AQ.; He, W.; Ahuja, SK.; Lutsar, I. (2014). Association between HIV-1 tropism and CCR5 human haplotype E in a Caucasian population. JAIDS: Journal of Acquired Immune Deficiency Syndromes, 66 (3), 239−244. DOI: 10.1097/QAI.0000000000000127.
 
Rüütel, Kristi; Karnite, Anda; Talu, Ave; Abel-Ollo, Katri; Kirvelaite, Gunta; Kliiman, Kai; Loit, Helle-Mai; Uusküla, Anneli. (2014). Prevalence of IGRA-positivity and risk factors for tuberculosis among injecting drug users in Estonia and Latvia. International Journal of Drug Policy, 25 (1), 175−178. DOI: 10.1016/j.drugpo.2013.10.002.
 
Rahu, K.; Bromet, E. J.; Hakulinen, T.; Auvinen, A.; Uusküla, A.; Rahu, M. (2014). Non-cancer morbidity among Estonian Chernobyl cleanup workers: a register-based cohort study. BMJ Open, 4, e004516. DOI: 10.1136/bmjopen-2013-004516.
 
Uusküla, A.; Raag, M.; Folch, C.; Prasad, L.; Karnite, A.; van Veen, M.G.; Eritsyan, K.; Rosinska, M.; Des Jarlais, D.C.; Wiessing, L. (2014). Self-reported testing, HIV status and associated risk behaviours among people who inject drugs in Europe: important differences between East and West. AIDS, 28 (11), 1657−64.10.1097/QAD.0000000000000299.
 
Liivlaid, H; Uusküla, A (2013). Changes in high-risk sexual behaviour among Estonian adults between 1996 and 2006. Sexually Transmitted Infections, 89 (2), 91−97.10.1136/sextrans-2012-050506.
 
Karnite, A.; Brigis, G.; Uusküla, A. (2013). Years of potential life lost due to HIV infection and associated factors based on national HIV surveillance data in Latvia, 1991-2010. Scandinavian Journal of Infectious Diseases, 45 (2), 140−146.10.3109/00365548.2012.717710.
 
Vickerman, P; Martin, NK; Roy, A; Beattie, T; EMCDDA Collaborative Group, Jarlais, DD; Strathdee, S; Wiessing, L; Hickman, M (2013). Is the HCV-HIV co-infection prevalence amongst injecting drug users a marker for the level of sexual and injection related HIV transmission? Drug and Alcohol Dependence, 132, 172−182.10.1016/j.drugalcdep.2013.01.020.
 
Laisaar, KT; Uusküla, A; Sharma, A; DeHovitz, JA; Amico, KR (2013). Developing an adherence support intervention for patients on antiretroviral therapy in the context of the recent IDU-driven HIV/AIDS epidemic in Estonia. AIDS Care, 25 (7), 863−873. DOI: 10.1080/09540121.2013.764393.
 
Huik, K; Avi, R; Pauskar, M; Kallas, E; Jõgeda, EL; Karki, T; Marsh, K; Des Jarlais, D; Uusküla, A; Lutsar, I (2013). Association between TLR3 rs3775291 and resistance to HIV among highly exposed Caucasian intravenous drug users. Infection Genetics and Evolution, 20, 78−82. DOI: 10.1016/j.meegid.2013.08.008.
 
Huik, K; Avi, R; Carrillo, A; Harper, N; Pauskar, M; Sadam, M; Karki, T; Krispin, T; He, W; Lutsar, I (2013). CCR5 Haplotypes Influence HCV Serostatus in Caucasian Intravenous Drug Users. PLoS ONE, 8 (7), e70561. DOI: 10.1371/journal.pone.0070561.
 
Uusküla, Anneli; Rajaleid, Kristiina; Talu, Ave; Abel-Ollo, Katri; Des Jarlais, Don (2013). A decline in the prevalence of injecting drug users in Estonia, 2005–2009. International Journal of Drug Policy, 24 (4), 312−318. DOI: 10.1016/j.drugpo.2012.11.002.
 
Vorobjov, S; Des Jarlais, DC; Abel-Ollo, K; Talu, A; Rüütel, K; Uusküla, A (2013). Socio-demographic factors, health risks and harms associated with early initiation of injection among people who inject drugs in Tallinn, Estonia: Evidence from cross-sectional surveys. International Journal of Drug Policy, 24 (2), 150−155. DOI: 10.1016/j.drugpo.2012.08.003.
 
Puur, A., Altmets, K., Saava, A., Uusküla, A., Sakkeus, L. (2013). Non-fatal injuries resulting in activity limitations in Estonia: risk factors and association with the incidence of chronic conditions and quality of life. A retrospective study among the population aged 20-79. BMJ Open, 3, 1−7. DOI: 10.1136/bmjopen-2013-002695.
 
Anneli Uusküla, A.; Müürsepp, A.; Kawai, K.; Raag, M.; Jürisson, M.; Pillsbury, M. (2013). The epidemiological and economic impact of a quadrivalent human papillomavirus (hpv) vaccine in Estonia. BMC Infectious Diseases, 13, No 304. DOI: 10.1186/1471-2334-13-304.
 
Uusküla, A.; Raag, M.; Uppin, A.; Raud, T.; Klaar, U.; Jürisson, M.; Müürsepp, A. (2013). Incidence of Cervical Intraepithelial Neoplasia in Estonia. Journal of Lower Genital Tract Disease, 17 (2), 129−136. DOI: 10.1097/LGT.0b013e3182652213.
 
Uusküla, A.; Laisaar, K.-T.; Raag, M.; Smidt, J.; Semjonova, S.; Kogan, J.; Amico K, R.; Sharma, A.; Dehovitz , J. (2012). Antiretroviral therapy (ART) adherence and correlates to nonadherence among people on ART in Estonia. AIDS Care, 24 (12), 1470−1479. DOI: 10.1080/09540121.2012.672724.
 
Vorobjov S, Uusküla A, Des Jarlais DC, Abel-Ollo K, Talu A, Rüütel K. (2012). Multiple routes of drug administration and HIV risk among injecting drug users. Journal of Substance Abuse Treatment, 42 (4), 413−420.
 
Uusküla, A.; Abel-Ollo, K.; Markina, A.; McNutt, LA.; Heimer, R. (2011). Condom use and partnership intimacy among drug injectors and their sexual partners in Estonia. Sexually Transmitted Infections, 88 (1), 58−62. DOI: 10.1136/sextrans-2011-050195.
 
Uusküla, A.; Kals, M; McNutt, LA. (2011). Assessing non-response to a mailed health survey including self-collection of biological material. European Journal of Public Health, 21 (4), 538−542.10.1093/eurpub/ckq053.
 
Laisaar, K.-T.; Avi, R.; Dehovitz, J.; Uusküla, A. (2011). Estonia at the Threshold of the Fourth Decade of the AIDS Era in Europe. Aids Research and Human Retroviruses, 27 (8), 841−851. DOI: 10.1089/aid.2010.0223.
 
Uusküla A, Des Jarlais DC, Kals M, Rüütel K, Abel-Ollo K, Talu A, Sobolev I. (2011). Expanded syringe exchange programs and reduced HIV infection among new injection drug users in Tallinn, Estonia. BMC Public Health, 30 (11), 517. DOI: 10.1186/1471-2458-11-517.
 
Altmets, K.; Puur, A. ; Uusküla, A.; Saava, A.; Sakkeus, L.; Katus, K. (2011). Self-reported activity limitations among the population aged 20-79 in Estonia: a cross-sectional study. European Journal of Public Health, 21 (1), 49−55. DOI: 10.1093/eurpub/ckp239.
 
Uusküla, A.; Kals, M.; Kosenkranius, L.; McNutt, LA.; DeHovitz, JJ. (2010). Population-based type-specific prevalence of high-risk human papillomavirus infection in Estonia. BMC Infectious Diseases, 10, Article Number: 63.10.1186/1471-2334-10-63.
 
Uusküla, A.; McMahon, JM.; Raag, M.; Silm, S.; Rüütel, K.; Talu, A.; Abel-Ollo, K.; Ahas, R.; Des Jarlais, DC. (2010). Emergent properties of HIV risk among injection drug users in Tallinn, Estonia: synthesis of individual and neighbourhood-level factors. Sexually Transmitted Infections, 86, 3, 79−84. DOI: 10.1136/sti.2009.040212.
 
Uusküla, A.; Johnston, L.G.; Raag, M.; Trummal, A.; Talu, A.; Des Jarlais, D.C. (2010). Evaluating recruitment among female sex workers and injecting drug users at risk for HIV using respondent driven sampling in Estonia. Journal of Urban Health, 87 (2), 304−317. DOI: 10.1007/s11524-009-9427-7.
 
Talu, A.; Rajaleid, K.; Abel-Ollo, K.; Rüütel, K.; Rahu, M.; Rhodes, T.; Platt, L.; Bobrova, N.; Uusküla, A. (2010). HIV infection and risk behaviour of primary fentanyl and amphetamine injectors in Tallinn, Estonia: Implications for intervention. International Journal of Drug Policy, 21 (1), 56−63. DOI: 10.1016/j.drugpo.2009.02.007.
 
Huik, K.; Sadam, M.; Karki, T.; Avi, R.; Krispin, T.; Paap, P.; Rüütel, K.; Uusküla, A.; Talu, A.; Abel-Ollo, K.; Lutsar, I. (2010). CCL3L1 copy number is a strong genetic determinant of HIV seropositivity in Caucasian intravenous drug users. The Journal of Infectious Diseases, 730−739. DOI: 10.1086/650491.
 
Uusküla A, Puur A, Toompere K, DeHovitz J. (2010). Trends in the epidemiology of bacterial sexually transmitted infections in Eastern Europe, 1995-2005: review. Sexually Transmitted Infections, 86, 6−14. DOI: 10.1136/sti.2009.037044.
 
McNutt, L.A.; Gordon, EJ; Uuskula, A. (2009). Informed recruitment in partner studies of HIV transmission: an ethical issue in couples research. BMC Medical Ethics, 10, 14.
 
Vorobjov, S.; Uusküla, A.; Abel-Ollo, K.; Talu, A.; Des Jarlais, D. (2009). Should pharmacists have a role in harm reduction services for IDUs? A qualitative study in Tallinn, Estonia. Journal of Urban Health, 86 (6), 918−928.
 
Abel-Ollo, K.; Rahu, M.; Rajaleid, K.; Talu, A.; Rüütel, K.; Platt, L.; Bobrova, N.; Rhodes, T.; Uusküla, A. (2009). Knowledge of HIV serostatus and risk behaviour among injecting drug users in Estonia. AIDS Care, 21 (7), 851−857.
 
Vorobjov, S.; Uuskula, A.; Abel-Ollo, K.; Talu, A.; Ruutel, K.; Des Jarlais, D.C. (2009). Comparison of injecting drug users who obtain syringes from pharmacies and syringe exchange programs in Tallinn, Estonia. Harm Reduction Journal, 6 (1), 3.
 
Uusküla, A.; Fischer, K.; Raudne, R.; Kilgi, H.; Krylov, R.; Salminen, M.; Brummer-Korvenkontio, H.; St Lawrence, J.; Aral, S. (2008). A study on HIV and hepatitis C virus among commercial sex workers in Tallinn. Sexually Transmitted Infections, 84 (3), 189−191. DOI: 10.1136/sti.2007.027664.
 
Uusküla, A.; Kals, M.; Denks, K.; Nurm, U.; Kasesalu, L.; Dehovitz, J.; McNutt, L.A. (2008). The prevalence of chlamydial infection in Estonia: a poplation-based survey. International Journal of STD & Aids, 19 (7), 455−458. DOI: 10.1258/ijsa.2008.007325.
 
Uusküla, A.; Kals, M.; Rajaleid, K.; Abel, K.; Talu, A.; Rüütel, K.; Platt, L.; Rhodes, T.; Dehovitz, J.; Des Jarlais, D. (2008). High-prevalence and high-estimated incidence of HIV infection among new injecting drug users in Estonia: need for large scale prevention programs. Journal of Public Health, 30 (2), 119−125. DOI: 10.1093/pubmed/fdn014.
 
Uusküla, A.; McNutt, L.A.; Dehovitz, J.; Fischer, K.; Heimer, R. (2007). High prevalence of blood-borne virus infections and high-risk behaviour among injecting drug users in Tallinn, Estonia. International Journal of STD & AIDS, 18 (1), 41−46.
 
Wilson, T.E.; Sharma, A.; Zilmer, K.; Kalikova, N.; Uusküla, A. (2007). The HIV prevention needs of injection drug users in Estonia. International Journal of STD & Aids, 18 (6), 389−391.
 
Uusküla, A.; Rajaleid, K.; Talu, A.; Abel, K.; Rüütel, K.; Hay, G. (2007). Estimating injection drug use prevalence using state wide administrative data sources: Estonia, 2004. Addiction Research & Theory, 15 (4), 411−424.
 
Uuskula, A.; Heimer, R.; DeHovitz, J.; Fischer, K.; McNutt, LA. (2006). Surveillance of HIV, hepatitis B virus, and hepatitis c virus in an Estonian injection drug-using population: Sensitivity and specificity of testing syringes for public health surveillance. The Journal of Infectious Diseases, 193 (3), 455−457.
 
Aral, S.O.; St Lawrence, J.S.; Uusküla, A. (2006). Sex Work in Tallinn, Estonia: The Socio-spatial Penetration of Sex Work into Society. Sexually Transmitted Infections, 82 (5), 348−353.
 
Platt, L.; Bobrova, N.; Rhodes, T.; Uusküla, A.; Parry, JV.; Rüütel, K.; Talu, A.; Abel, K.; Rajaleid, K.; Judd, A. (2006). High HIV prevalence among injecting drug users in Estonia: implications for understanding the risk environment. AIDS, 20 (16), 2120−2123.
 
Uuskula, A.; Kangur, K.; McNutt, L.A. (2006). Barriers to effective STI screening in a post-Soviet society: results from a qualitative study. Sexually Transmitted Infections, 82 (4), 323−326.
 
Rüütel, K.; Uusküla, A. (2006). HIV epidemic in Estonia in the third decade of AIDS era. Scandinavian Journal of Infectious Diseases, 38 (3), 181−186.
 
Naaber, P.; Uuskula, A.; Naaber, J.; Poder, A.; Hjelm, E.; Hallen, A.; Unemo, M.; Domeika, M. (2005). Laboratory diagnosis of sexually transmitted infections in Estonia in 2001-2002: Shortcomings with impact on diagnostic quality and surveillance. Sexually Transmitted Diseases, 32 (12), 759−764.
 
Uuskula, A.; Raukas, E. (2004). Atypical genital herpes: Report of five cases. Scandinavian Journal of Infectious Diseases, 36 (1), 37−39.
 
Uuskula, A.; Nygard-Kibur, M.; Cowan, FM.; Mayaud, P.; French, RS.; Robinson, JNR.; Brown, DWG. (2004). The burden of infection with herpes simplex virus type 1 and type 2: Seroprevalence study in Estonia. Scandinavian Journal of Infectious Diseases, 36 (10), 727−732.
 
Uuskula, A.; McNutt, LA.; Dehovitz, J. (2004). Treatment of sexually transmitted diseases in Estonia - Consistency with the evidence-based medicine principles. Sexually Transmitted Diseases, 31 (10), 631−635.
 
Uuskula, A.; Nygard, JF.; Kibur-Nygard, M. (2004). Syphilis as a social disease: experience from the post-communist transition period in Estonia. International Journal of STD & Aids, 15 (10), 662−668.
 
Cowan, FM.; French, RS.; Mayaud, P.; Gopal, R.; Robinson, NJ.; de Oliveira, SA.; Faillace, T.; Uuskula, A.; Nygard-Kibur, M.; Ramalingam, S.; Sridharan, G.; El Aouad, R.; Alami, K.; Rbai, M.; Sunil-Chandra, NP.; Brown, DW. (2003). Seroepidemiological study of herpes simplex virus types 1 and 2 in Brazil, Estonia, India, Morocco, and Sri Lanka. Sexually Transmitted Infections, 79 (4), 286−290.
 
Uuskula, A.; Kohl, PK. (2002). Genital mycoplasmas, including Mycoplasma genitalium, as sexually transmitted agents. International Journal of STD & Aids, 13 (2), 79−85.
 
Uuskula, A.; Plank, T.; Lassus, A.; Bingham, JS. (2001). Sexually transmitted infections in Estonia - syndromic management of urethritis in a European country? International Journal of STD & AIDS, 12 (8), 493−498.
 
Wilson, TE.; Uuskula, A.; Feldman, J.; Holman, S.; Dehovitz, J. (2001). A case-control study of beliefs and behaviors associated with sexually transmitted disease occurrence in Estonia. Sexually Transmitted Diseases, 28 (11), 624−629.
 
Uuskula, A.; Silm, H.; Vessin, T. (1997). Sexually transmitted diseases in Estonia: Past and present. International Journal of STD & Aids, 8 (7), 446−450.
1.3. Eelretsenseeritud teadusartiklid Eesti ja teiste riikide eelretsenseeritavates teadusajakirjades, millel on kohalik toimetuskolleegium, või eelretsenseeritud teadusartiklid Eesti kultuurile olulistes ajakirjades või teadusartiklid ajakirjades Akadeemia, Looming ja Vikerkaar.
 
Anderson, Eva; Toompere, Karolin; Reile, Rainer; Uusküla, Anneli (2013). Naiste teadlikkus emakakaelavähki ennetavatest meetmetest Eestis 2011. aastal. Eesti Arst, 92 (4), 195−203.
 
Uusküla, A (2013). Ajas muutuvad eesmärgid. Eesti Arst, 92 (5), 244−246.
 
Uusküla, A. (2011). KONSTANDID NÕUAVAD TÄHELEPANU. Akadeemia, 1, 144−152.
 
Saava, Astrid;Puur, Allan;Altmets, Katre;Sakkeus, Luule;Uusküla, Anneli (2011). Toimetulekupiiranguid põhjustanud vigastused Eestis: rahvastikupõhine sündmuslooline uuring. Eesti Arst, 90, 4, 165−173.
 
Uusküla, A.; Jürisson, M.; Võrk, A.; Kallikorm, R. (2009). Sõeluuringu rakendamise põhjendatus osteoporoosi varaseks diagnoosimiseks Eestis. Eesti Arst, 402−413.
 
Altmets, K.; Katus, K.; Puur, A.; Saava, A.; Uusküla, A. (2008). Toimetulekupiirangud Eesti täisealises rahvastikus - levimus ja tegelik abistamine. Eesti Arst, 87 (2), 92−101.
 
Kangur, A.; Põder, A.; Maimets, M.; Silm, H.; Kukk, T.; Uusküla, A.; Rajangu, H.; Brilene, T.; Zilmer, K.; Saarma, I.; Karro, H.; Tammemäe, L.; Szirko, F.; Timberg, G.; Punab, M.; Kallikorm, R. (2007). Seksuaalsel teel levivate infektsioonide Eesti ravijuhend 2007. I. Omandatud süüfilis. Eesti Arst, 86 (10), 770−777.
 
Uusküla, A. (2004). Sugulisel teel levivad infektsioonid ja nende ravi HIV-infektsiooni ennetuses. Eesti Arst, 83 (3), 186−191.
 
Ahas, R.; Roosaare, J.; Uusküla, A.; Silm, S. (2004). Eestlaste sündide aastaajalisusest. Akadeemia, 12, 2563−2589.
 
Uusküla, A.; Silm, H. (2000). Genitaalsed mükoplasmainfektsioonid. Eesti Arst, 5, 282−286.
6.6. Muudes ajakirjades ja ajalehtedes avaldatud artiklid;
 
Põder, A.; Uusküla, A.; Vendirevskih, G.; Silm, H.; Raukas, E.; Brilene, T. (1999). Meeste uretriidi ja naiste endotservitsiidi/kolpiidi etioloogiline struktuur Eestis. Eesti Naistearstide Seltsi Teataja, 9, 36−41.
6.8. Lühikirjutised teadusajakirjades ja kogumikes
 
Veerus, Piret; Salumets, Andres; Naaber, Paul; Krjutškov, Kaarel; Tilk, Kadi; Laanpere, Made; Uusküla, Anneli (2020). Seroprevalence of SARS-CoV-2 antibodies among pregnant women in Estonia: A call for epidemiological studies. Acta Obstetricia Et Gynecologica Scandinavica, 99 (12), 1736−1737. DOI: 10.1111/aogs.13995.
 
Uusküla, Anneli; Jarlais, Don Des; Vorobjov, Sigrid (2019). The fentanyl epidemic in Estonia: opportunities for a comprehensive public health response. The Lancet Psychiatry, 6 (12), 985−985. DOI: 10.1016/S2215-0366(19)30436-5.
21.07.2022

Otsi projekti

  • {{item.Name}}
Asutus on projekti finantseerija   Asutus on projekti teostaja  
  • {{searchListItem.Name}}
Kõik   Tavaprojektid   Ülemprojektid   Alamprojektid  
Uus Frascati (2015)
Uus ja vana Frascati (otsing uue järgi väljastab ka seotud vanad)
Kõik
Käimasolevad
Lõppenud
Algus
Hajus
Täpne
Uus otsing (Beetaversioon) Lihtotsing Tühjenda
  • Leitud 41 kirjet
ProgrammLiikNumberNimiProjekti algusProjekti lõppVastutav täitjaAsutusFinantseerijapoolne rahastamine
2.1.1.LMVPT22288BioBlock® kontseptsiooni tõestuste uuring11.03.202215.11.2022Ruth KaldaTartu Ülikool, Meditsiiniteaduste valdkond, peremeditsiini ja rahvatervishoiu instituut32 910,00 EUR
MUUSARTH12115T (3.2.1001.11-0020)Bridging the gap in knowledge and practice of prevention and care for HIV in Estonia24.10.201131.08.2015Anneli UuskülaTartu Ülikool514 964,50 EUR
MUUMARTH07245Capacity building for disease surveillance and health monitoring in Estonia.01.12.200730.04.2011Anneli UuskülaTartu Ülikool769 311,99 EUR
MUUMARTH04069Collaborative response to Tackle HIV Epidemic in Baltics: International and Multidisciplinary Workshop to Prioritize Areas and Methods of Research / HIV nakkus ja sellega seostuvad probleemid Balti riikides - teadusuuringute ja ennetustegevuse priori01.07.200431.12.2004Anneli UuskülaTartu Ülikool13 003,08 EUR
MUUMARTH15062Combined prevention to reduce initation into injecting drug use01.03.201531.01.2016Anneli UuskülaTartu Ülikool, Arstiteaduskond, Tervishoiu instituut; Tartu Ülikool, Meditsiiniteaduste valdkond, peremeditsiini ja rahvatervishoiu instituut138 000,00 EUR
1.1.5.SMVPT20243COVID-19 aktiivne seire23.04.202031.12.2020Mikk JürissonTartu Ülikool, Meditsiiniteaduste valdkond, peremeditsiini ja rahvatervishoiu instituut1 800 000,00 EUR
1.1.5.SMVPT20599COVID-19 AKTIIVNE SEIRE-211.11.202031.05.2021Mikk JürissonTartu Ülikool, Meditsiiniteaduste valdkond, peremeditsiini ja rahvatervishoiu instituut1 607 238,91 EUR
1.1.5.3.14SMVPT21269T (2014-2020.15.01.22-0162)COVID-19 AKTIIVNE SEIRE-301.05.202131.12.2022Mikk JürissonTartu Ülikool, Meditsiiniteaduste valdkond, peremeditsiini ja rahvatervishoiu instituut2 692 908,00 EUR
RITA1AlamprojektRITA1/02-120-01COVID-19 haigusjuhtumite analüüs ja riskirühmade väljaselgitamine Eestis14.09.202021.03.2022Anneli UuskülaTartu Ülikool, Meditsiiniteaduste valdkond, peremeditsiini ja rahvatervishoiu instituut148 061,00 EUR
RITA1ÜlemprojektRITA1/02-120COVID-19 haigusjuhtumite analüüs ja riskirühmade väljaselgitamine Eestis14.09.202021.03.2022Anneli UuskülaTartu Ülikool530 000,00 EUR
MUUMARTH06177Development of an Intervention/Prevention to Block Transmission from Injection Drug Users to Their Sex Partners, Culturally Appropriate for Ethnic and Non-Ethnic Estonians in Estonia.07.08.200606.01.2008Anneli UuskülaTartu Ülikool46 037,93 EUR
SFSF0182648s04Eesti elanike tervise seisundit mõjutavad tegurid: mõõtmismetoodika ja sekkumiste tulemuslikkus.01.01.200431.12.2008Anneli UuskülaTartu Ülikool, Arstiteaduskond302 800,62 EUR
MUULP2EC14127Eesti meeste hoiakute ja käitumise uuring: tervis, haridus, tööhõive, ränne ja pereloome15.08.201412.01.2015Kerly EspenbergTartu Ülikool; Tartu Ülikool, Tartu Ülikooli Euroopa Kolledž, Rakendusuuringute keskus Socialia39 993,75 EUR
EMPEMP416Emakakaelavähi likvideerimisele suunatud nutikad ja personaalsed lahendused sõeluuringuks01.02.202031.07.2023Anneli UuskülaTartu Ülikool, Meditsiiniteaduste valdkond, peremeditsiini ja rahvatervishoiu instituut286 799,00 EUR (kogurahastus 907 847,00 EUR)
1.2.3.4.MMVPT21144R (964049)Emakakaelavähi sõeluuringu tõhustamine Euroopa riikides01.03.202128.02.2026Anneli UuskülaTartu Ülikool, Meditsiiniteaduste valdkond, peremeditsiini ja rahvatervishoiu instituut167 122,50 EUR
ETFETF7416Enneaegne suremus ja alkoholi tarvitamine: Eesti andmebaaside ja terviseuuringute süvaanalüüs tõendupõhise teabe saamiseks01.01.200831.12.2010Kersti PärnaTartu Ülikool, Arstiteaduskond34 759,25 EUR
IUTIUT34-17Epidemioloogilised ja rahvatervise uuringud tõenduspõhiseks otsustamiseks ja siirdemeditsiini toetamiseks01.01.201531.12.2020Anneli UuskülaTartu Ülikool, Meditsiiniteaduste valdkond, peremeditsiini ja rahvatervishoiu instituut399 600,00 EUR
MUUMARTH08018European network for promoting health of residents in psychiatric and social care institutions (Psühhiaatriliste raviasutuste ja hooldekodude teenuste kasutajate füüsilise tervise edendamise Euroopa võrgustik)01.01.200831.12.2010Anneli UuskülaTartu Ülikool22 934,95 EUR
MUUMARTH10189Genitaaltüügaste levimus: uuring kolmes Balti riigis01.12.201030.11.2012Anneli UuskülaTartu Ülikool; Tartu Ülikool, Arstiteaduskond, Tervishoiu instituut86 500,01 EUR
MUUMARTH08228HIV ülekanne narkootikumide kasutajate hulgas Tallinnas, Eestis01.01.200930.07.2010Anneli UuskülaTartu Ülikool35 727,89 EUR
MUUMARTH07237HIV-nakkuse kandjate HAART ravisoostumus ja seda mõjutavad tegurid01.01.200730.09.2011Anneli UuskülaTartu Ülikool; Tartu Ülikool, Arstiteaduskond, Tervishoiu instituut68 555,79 EUR
MUUMARTH10174HIVi levikut mõjutavad tegurid ja teenuste kättesaadavus venemaal ja Eestis elavate süstivate narkomaanide seas01.09.201031.08.2015Anneli UuskülaTartu Ülikool; Tartu Ülikool, Arstiteaduskond, Tervishoiu instituut398 639,07 EUR
2.2.1.VMVPT20663Infrastruktuuri arendamine ja COVID-19 vaktsiini tõhususe uuringute läbiviimine Euroopa Liidus07.12.202031.10.2021Anneli UuskülaTartu Ülikool, Meditsiiniteaduste valdkond, peremeditsiini ja rahvatervishoiu instituut75 000,00 EUR
2.2.1.VMVPT21550Infrastruktuuri arendamine ja COVID-19 vaktsiini tõhususe uuringute läbiviimine Euroopa Liidus (jätkuprojekt)24.08.202124.02.2022Anneli UuskülaTartu Ülikool, Meditsiiniteaduste valdkond, peremeditsiini ja rahvatervishoiu instituut122 616,00 EUR
MUULARTH08107Inimese papilloomiviiruse (HPV) levimuse hindamine.01.06.200830.09.2008Anneli UuskülaTartu Ülikool6 454,76 EUR